CHEMICAL, BIOLOGICAL, RADIOLOGICAL, AND NUCLEAR DEFENSE (CBRND) FUNCTIONAL NEEDS ANALYSIS. FINAL REPORT (2005)

For Official Use Only

CBRND Functional Needs Analysis/Functional Solution Analysis

Chapter 17. Tactical Sustain Tasks

17.8

Task TASUST 8: Treat chemical effects on personnel and MWAs

17.8.1

Functional Area Analysis

17.8.1.1

Definition

To provide rapid treatment and mitigation of health effects of chemical agents, including TICs,

exposure to personnel and MWAs, specifically MWDs. Treatment includes the protocols and

procedures for the administration of the treatment regime as well as the logistical requirements

necessary to support surge operations required by the mass exposure of personnel.

17.8.1.2

Derivation

UJTL (TA 7, TA 7.1), Protection Joint Functional Concept.

17.8.1.2.1

Supported Tasks: OPSUST 8, OPSUST 11

17.8.1.2.2

Lateral Task: TASHA 24

17.8.1.2.3

Supporting Task: N/A

17.8.1.3

Condition

Perform this task under conditions of:

Physical

1. Negligible light. (C1.3.2.1)

2. Chemical effects. (C1.3.3.2)

Military

1. Severe health status. (NEW)

2. Stressful mission. (C2.1)

3. Minimal or short time available. (C2.1.5)

4. Marginal forces allocated. (C2.2.3)

5. Low personnel capability. (C2.2.4)

6. Limited or negligible personnel experience. (C2.2.4.5)

7. Severe personnel fatigue. (C2.2.4.6)

8. Some or no interoperability. (C2.2.6)

9. Restricted information exchange. (C2.3.1.8)

Civil

1. High mission priority. (C3.1.3.2)

2. Few or negligible translators. (C3.2.1.2)

3. Significant customs adjustment. (C3.2.2)

For Official Use Only

CBRND Functional Needs Analysis/Functional Solution Analysis

Chapter 17. Tactical Sustain Tasks

4. Significant refugee-care responsibility. (C3.3.2.3)

17.8.2

Functional Needs Analysis

17.8.2.1

Capabilities and Deficiencies Assessment Summary

Table 17.8-1 presents individual and overall current, near-/mid-term, and far-term capabilities to

perform the task to the designated standards. There are 13 current capabilities used to accomplish

this task and one projected capability to be added in the future (one in the near/mid term). The

capabilities include a range of MWD handler and Veterinary Services personnel-administered

post-exposure therapeutics with differing capabilities to meet the identified standards.

Current Capabilities and Deficiencies.

The overall current capability is assessed as “yellow.” Multiple nerve agent therapeutics exist for

personnel, and many of these can also be used “extra label” in MWAs. If administered

immediately after exposure, they are usually effective. Nevertheless, there are severe

contraindications associated with many of these therapeutics, and most of them are required to be

given under the supervision of medical or veterinary personnel.

There are no FDA-approved therapeutics for personnel or MWA exposure to blister agents with

the exception of symptomatic treatment and supportive care. Dimercaprol (a.k.a. British Anti-

Lewisite) is not FDA approved for either personnel or MWAs, though it can be used “extra

label” in MWAs.

Effective therapeutics for cyanide intoxication (both through respiration and ingestion) exist.

However, many are given intravenously, and most require medical or veterinary personnel for

administration. Though none of the cyanide therapeutics are FDA approved for MWAs, they can

be used “extra label” for MWAs.

Like blister agent therapeutics, pulmonary agent therapeutics are based on symptomatic

treatment and supportive care. Many of these therapeutics have major contraindications and are

not readily available for MWA care, and most, if not all, must be administered under the

supervision of medical or veterinary personnel.

Current deficiencies include the lack of vesicant and pulmonary agent antidotes and the lack of

effective nerve, vesicant, and pulmonary agent exposure therapeutics that do not have significant

adverse effects and that can be readily administered by MWD handlers.

Projected Near/Mid-Term Capabilities and Deficiencies

The overall projected near/mid-term capability is assessed as “yellow.” In the near/mid-term

future, the Advanced Anticonvulsant System (AAS) is expected to replace the convulsive

antidote for nerve agent. The protection against seizures caused by nontraditional chemical

agents provided by the midazolam-containing AAS will be superior to that provided by the

For Official Use Only

CBRND Functional Needs Analysis/Functional Solution Analysis

Chapter 17. Tactical Sustain Tasks

Measures

FAA Measure

Elaboration

Scale

Therapeutics are FDA

10: FDA approved for use in both personnel and MWAs.

approved?

5: Not FDA approved in personnel and/or MWAs; can be used “extra label” for

personnel and/or MWAs.

0: Cannot be used in either personnel or MWAs.

Therapeutics exist for

Effectiveness of a particular

10: Complete capability (effective for all chemical hazards of a certain type).

all chemical hazards?

therapeutic for chemical hazards of a

5: Partial capability (limited effectiveness for one or more chemical hazards of a

certain type (i.e., nerve agents, blister

certain type).

agents, cyanides, and pulmonary

0: No capability.

agents).

Capability (DOTLPF)

10: DOTLPF exists and is adequate for this task. Task can be effectively performed

exists to treat chemical

with minor limitations with little or no direct impact upon operations.

exposure?

5: Most critical aspects of DOTLPF for this task are addressed.

0: DOTLPF is inadequate or does not exist for this task. Task cannot be effectively

accomplished.

For Official Use Only

CBRND Functional Needs Analysis/Functional Solution Analysis

Chapter 17. Tactical Sustain Tasks

17.8.3

Functional Solution Analysis

17.8.3.1

DOTLPF Assessment Summary

This section states the deficiencies and suggests potential non-materiel solutions. If there are no

solutions or there are only partial solutions for a particular deficiency, that deficiency is then

reassessed in the IMA section.

Deficiency: Lack of animal testing to support efficacy and administration of many

therapeutics for nerve agent exposure.

Non-Materiel Solutions: Doctrine: Develop doctrine based on results of future tests on

animal models.

Deficiency: Limited efficacy of oximes on quickly “aging” agents such as soman.

Non-Materiel Solutions: None.

Deficiency: Significant adverse effects or contraindications for some nerve agent

therapeutics, including ATNAA and benzodiazepine receptor agonists.

Non-Materiel Solutions: None.

Deficiency: Lack of therapeutics including MANAA, memantine, midazolam, and lorazepam

that are packaged for self- or buddy-administration or administration by a MWD handler

(These usually require administration by a physician or veterinarian).

Non-Materiel Solutions: Personnel (Partial): Increase number of physicians and

veterinarians that can administer and monitor treatment. Training (Partial): Train

nonmedical personnel and MWD handlers to administer therapeutics under limited

circumstances.

Deficiency: Lack of resources to prevent mass casualty diagnostic requirements from

overwhelming the laboratory system.

Non-Materiel Solutions: Doctrine (Partial): Revise doctrine to define those circumstances

when assistance from alternative laboratories would be needed, to identify which staff and

what equipment would be readily available to conduct diagnostics, to clarify DoD

requirements for personnel (i.e., clearance, experience, etc.), to identify what protocol for

diagnosing/analyzing samples are to be followed, and to ensure adequate training of

personnel. Organization (Partial): Develop MOU/As with civilian and/or commercial

laboratories to assist with diagnostic requirements. Training (Partial): Coordinate training

and certify personnel from alternative laboratories.

Deficiency: Lack of effective and rapidly acting therapeutics for high-level cyanide

exposure.

Non-Materiel Solutions: None.

Deficiency: Significant adverse effects and contraindications of cyanide therapeutics such as

Pasadena Cyanide Antidote Kit and Sodium Thiosulfate.

Non-Materiel Solutions: None.

For Official Use Only

CBRND Functional Needs Analysis/Functional Solution Analysis

Chapter 17. Tactical Sustain Tasks

8. Deficiency: Required physician or veterinarian administration and monitoring of cyanide

therapeutics such as Pasadena Cyanide Antidote and Sodium Thiosulfate.

Non-Materiel Solutions: Personnel (Partial): Increase number of physicians and

veterinarians that can administer and monitor treatment.

9. Deficiency: Inability of MWD handlers to give current pulmonary agent therapeutics (must

be given at Level II, III or IV).

Non-Materiel Solutions: None.

10. Deficiency: Lack of pulmonary agent antidote.

Non-Materiel Solutions: None.

11. Deficiency: Significant adverse effects and contraindications of symptomatic treatment and

supportive care for pulmonary agent exposure.

Non-Materiel Solutions: None.

12. Deficiency: Required physician or veterinarian supervision and monitoring of intravenously

administered drugs such as corticosteriods and aminophylline.

Non-Materiel Solutions: Personnel (Partial): Increase number of physicians and

veterinarians that can administer and monitor treatment. Training (Partial): Train

nonmedical personnel and MWD handlers to administer therapeutics under limited

circumstances.

13. Deficiency: Lack of animal testing to support efficacy and administration of many

therapeutics for pulmonary agent exposure.

Non-Materiel Solutions: Doctrine (Partial): Develop doctrine based on results of future

tests on animal models.

14. Deficiency: Lack of vesicant agent antidote.

Non-Materiel Solutions: None.

15. Deficiency: Lack of animal testing to support efficacy and administration of many

therapeutics for vesicant agent exposure.

Non-Materiel Solutions: Doctrine: Develop doctrine based on results of tests on animal

models.

17.8.3.2

IMA Assessment Summary

Table 17.8-2 identifies which of the materiel approaches might address specific materiel gaps

identified in the DOTMLPF assessment.

For Official Use Only

For Official Use Only

CBRND Functional Needs Analysis/Functional Solution Analysis

Chapter 17. Tactical Sustain Tasks

Table 17.8-2. TASUST 8: IMA Assessment

Idea for Materiel

Approach

(IMA)

Identified Gap

Nerve Agents

Limited efficacy of oximes on quickly “aging” agents such soman.

Significant adverse effects or contraindications for some nerve agent

therapeutics including ATNAA and benzodiazepine receptor agonists.

Lack of therapeutics including MANAA, memantine, midazolam and

lorazepam that packaged for self- or buddy-administration or

administration by a MWD handler (these usually require

administration by a physician or veterinarian).

Cyanides

Lack of effective and rapidly acting therapeutics for high-level

cyanide exposure.

Significant adverse effects and contraindications of cyanide

therapeutics such as Pasadena Cyanide Antidote Kit and Sodium

Thiosulfate.

Required physician or veterinarian administration and monitoring of

Pasadena Cyanide Antidote and Sodium Thiosulfate.

Pulmonary Agents

Inability of MWD handlers to give current pulmonary agent

therapeutics (must be given at Level II, III or IV).

Lack of pulmonary agent antidote.

For Official Use Only

CBRND Functional Needs Analysis/Functional Solution Analysis

Chapter 17. Tactical Sustain Tasks

17.9

Task TASUST 9: Treat biological effects on personnel and MWAs

17.9.1

Functional Area Analysis

17.9.1.1

Definition

To provide rapid treatment and mitigation of health effects of biological agent exposure to

personnel and MWAs, specifically MWDs. Treatment includes the protocols and procedures for

the administration of the treatment regime as well as the logistical requirements necessary to

support surge operations required by the mass exposure of personnel.

17.9.1.2

Derivation

UJTL (TA 7, TA 7.1), Protection Joint Functional Concept.

17.9.1.2.1

Supported Tasks: OPSUST 8, OPSUST 11

17.9.1.2.2

Lateral Task: TASHA 24

17.9.1.2.3

Supporting Task: N/A

17.9.1.3

Condition

Perform this task under conditions of:

Physical

1. Negligible light. (C1.3.2.1)

2. Biological effects. (C1.3.3.3)

Military

1. Severe health status. (NEW)

2. Stressful mission. (C2.1)

3. Minimal or short time available. (C2.1.5)

4. Marginal forces allocated. (C2.2.3)

5. Low personnel capability. (C2.2.4)

6. Limited or negligible personnel experience. (C2.2.4.5)

7. Severe personnel fatigue. (C2.2.4.6)

8. Some or no interoperability. (C2.2.6)

9. Restricted information exchange. (C2.3.1.8)

Civil

1. High mission priority. (C3.1.3.2)

2. Few or negligible translators. (C3.2.1.2)

3. Significant customs adjustment. (C3.2.2)

For Official Use Only

CBRND Functional Needs Analysis/Functional Solution Analysis

Chapter 17. Tactical Sustain Tasks

4. Moderate or high health risk. (C3.3.1.5)

5. Significant refugee-care responsibility. (C3.3.2.3)

17.9.2

Functional Needs Analysis

17.9.2.1

Capabilities and Deficiencies Assessment Summary

Table 17.9-1 presents individual and overall current, near-/mid-term, and far-term capabilities to

perform the task to the designated standards. There are three current capabilities used to

accomplish this task and one projected capability to be added in the future (one in the near/mid

term). The capabilities include a range of physician-administered post-exposure therapeutics

with differing capabilities to meet the identified standards.

Current Capabilities and Deficiencies

The overall current capability is assessed as “yellow.” Many effective antibiotics exist to treat

personnel and MWAs¹ infected with bacteria/rickettsia of interest. Many are FDA approved for

use in both personnel and MWAs²; those that are not can usually be used “extra label.”

There are very few effective antivirals for viruses of interest. Ribavirin is an investigational new

drug (IND) for Lassa fever. There are no effective antivirals for Ebola/Marburg, the equine

encephalitis viruses, or smallpox.

There are no antitoxins for most toxins of interest. While an FDA-approved trivalent antitoxin

exists for botulinum, there are no effective antitoxins (FDA-approved, IND, or otherwise) for

ricin, SEB, or T-2 mycotoxins.

Projected Near/Mid-Term Capabilities and Deficiencies

According to the analysis methodology, the overall projected near/mid-term capability is

assessed as “red.” The apparent decrement in capability from the current to near/mid-term future

is actually an artifact of the analysis. In all assessed tasks, DOTLPF is evaluated for the current

capability, but not for future capabilities. The projected near/mid-term capability will not likely

be inferior to the current capability. Near/mid-term future capability ABthrax^TM is currently

under development in Phase I clinical trials.

Projected Far-Term Capabilities and Deficiencies

No changes in capability are projected in the far term for this task, so the overall projected far-

term capability will remain “red.” Once again, the apparent decrement in capability from the

¹ Of the diseases considered to be likely BW agents, MWDs are likely to be susceptible to only plague (Yersinia pestis),

tularemia, brucellosis, Q-fever, and anthrax. In all of these diseases the MWD is believed to be less susceptible than man.

² One of the key doctrinal elements is that the DoD MWD Veterinary Service currently recommends that all MWDs deployed to

areas with high risk of natural tick-borne rickettsial disease be placed on prophylactic doxycycline at 6 mg/kg/day. Doxycycline

is generally considered efficacious against each of the diseases of concern and this prophylactic dose may provide additional

protection for MWDs against BW agents. Doxycycline is not currently approved by the FDA for use in animals.

For Official Use Only

For Official Use Only

CBRND Functional Needs Analysis/Functional Solution Analysis

Chapter 17. Tactical Sustain Tasks

Table 17.9-1. TASUST 9: Capabilities and Deficiencies Assessment

System/Measure

Current

Bacteria/Rickettsia

Antibiotics

Viruses

Antivirals

Toxins

Antitoxins

Near/Mid-Term

Bacteria/Rickettsia

Antibiotics

Unk

N/A

Current and Overall Capabilities

Near/Mid-Term Overall Capabilities

N/A

Far-Term Overall Capabilities

N/A

FAA Measure

Elaboration

Scale

Therapeutics are FDA

10: FDA approved for use in both personnel and MWAs.

approved?

5: Not FDA approved in personnel and/or MWAs; can be used “extra label” for

personnel and/or MWAs.

0: Not FDA approved in either personnel or MWAs; cannot be used “extra label” for

personnel and/or MWAs.

Therapeutics exist for all

Effectiveness of a particular

10: Complete capability (effective for all biological hazards of a certain type).

biological hazards?

therapeutic for biological hazards

5: Partial capability (limited effectiveness for one or more biological hazards of a

of a certain type (i.e., bacteria/

certain type).

rickettsia, viruses, and toxins).

0: No capability.

Capability (DOTLPF)

10: DOTLPF exists and is adequate for this task. Task can be effectively performed

exists to treat biological

with minor limitations with little or no direct impact upon operations.

exposure?

5: Most critical aspects of DOTLPF for this task are addressed.

0: DOTLPF is inadequate or does not exist for this task. Task cannot be effectively

accomplished.

For Official Use Only

CBRND Functional Needs Analysis/Functional Solution Analysis

Chapter 17. Tactical Sustain Tasks

17.9.3

Functional Solution Analysis

17.9.3.1

DOTLPF Assessment Summary

This section states the deficiencies and suggests potential non-materiel solutions. If there are no

solutions or there are only partial solutions for a particular deficiency, that deficiency is then

reassessed in the IMA section.

Deficiency: Lack of FDA-approved therapeutic for Glanders/Meliodosis.

Non-Materiel Solutions: Leadership: Obtain FDA-approval for off-label antibiotics

effective for treating glanders/meliodosis.

Deficiency: Doctrine does not reflect the most up-to-date treatment recommendations.

Non-Materiel Solutions: Doctrine: Update doctrine to reflect most up-to-date treatment

guidelines, or identify source of most up-to-date guidelines (Centers for Disease Control,

Military Surgeon General, etc).

Deficiency: Training does not include the most up-to-date treatment recommendations.

Non-Materiel Solutions: Training: Update training to reflect most up-to-date treatment

guidelines.

Deficiency: Lack of resources to prevent mass casualty diagnostic requirements from

overwhelming the laboratory system.

Non-Materiel Solutions: Doctrine (Partial): Revise doctrine to define those circumstances

when assistance from alternative laboratories would be needed, to identify which staff and

what equipment would be readily available to conduct diagnostics, to clarify DoD

requirements for personnel (i.e., clearance, experience, etc.), to identify what protocol for

diagnosing/analyzing samples are to be followed, and to ensure adequate training of

personnel. Organization (Partial): Develop MOU/As with civilian and/or commercial

laboratories to assist with diagnostic requirements. Training (Partial): Coordinate training

and certify personnel from alternative laboratories.

Deficiency: Insufficient medical facilities, resources, and personnel to deal with casualties.

Non-Materiel Solutions: Doctrine (Partial): Revise doctrine to define those circumstances

when supplemental medical care would be needed; to identify which staff and what

equipment could be readily transported for situations where medical resources need to be

deployed (i.e., for cases when transporting large numbers of casualties to medical treatment

facilities is not an option). Organization (Partial): Establish MOU/As with neighboring

medical facilities (civilian hospitals, clinics, etc) to assist with surge capacity. Training:

Coordinate exercises and training with personnel from alternate medical resources.

Personnel: Obtain alternate sources of personnel or cross train individuals. Facilities: Obtain

surge capacity through use of nonmilitary assets or use other military facilities for medical

purposes (dual use).

Deficiency: Lack of therapeutics for any of the toxins of interest, except for botulinum toxin.

Non-Materiel Solutions: None.

For Official Use Only

CBRND Functional Needs Analysis/Functional Solution Analysis

Chapter 17. Tactical Sustain Tasks

17.10 Task TASUST 10: Treat radiological effects on personnel and MWAs

17.10.1

Functional Area Analysis

17.10.1.1

Definition

To provide rapid treatment and mitigation of health effects of radiological agent exposure to

personnel and MWAs, specifically MWDs. Treatment includes the protocols and procedures for

the administration of the treatment regime as well as the logistical requirements necessary to

support surge operations required by the mass exposure of personnel.

17.10.1.2

Derivation

UJTL (TA 7, TA 7.1), Protection Joint Functional Concept.

17.10.1.2.1

Supported Tasks: OPSUST 8, OPSUST 11

17.10.1.2.2

Lateral Task: TASHA 24

17.10.1.2.3

Supporting Task: N/A

17.10.1.3

Condition

Perform this task under conditions of:

Physical

1. Negligible light. (C1.3.2.1)

2. Nuclear effects. (C1.3.3.1)

Military

1. Severe health status. (NEW)

2. Stressful mission. (C2.1)

3. Minimal or short time available. (C2.1.5)

4. Marginal forces allocated. (C2.2.3)

5. Low personnel capability. (C2.2.4)

6. Limited or negligible personnel experience. (C2.2.4.5)

7. Severe personnel fatigue. (C2.2.4.6)

8. Some or no interoperability. (C2.2.6)

9. Restricted information exchange. (C2.3.1.8)

Civil

1. Few or negligible translators. (C3.2.1.2)

2. Significant customs adjustment. (C3.2.2)

3. Significant refugee-care responsibility. (C3.3.2.3)

For Official Use Only

CBRND Functional Needs Analysis/Functional Solution Analysis

Chapter 17. Tactical Sustain Tasks

17.10.2

Functional Needs Analysis

17.10.2.1

Capabilities and Deficiencies Assessment Summary

Table 17.10-1 presents individual and overall current, near-/mid-term, and far-term capabilities

to perform the task to the designated standards. There is one family of current capabilities used

to accomplish this task. It includes a range of MWD handler-, Veterinary Services-, and medical

personnel-administered post-exposure therapeutics.

Current Capabilities and Deficiencies

The overall current capability is assessed as “yellow.” Therapeutics and symptomatic care are

available for all radiological agents, though they typically have short-lived activity and can have

toxic effects. Most therapeutics simply block absorption or expedite excretion of internalized

radiological materials. Symptomatic care can include treatment to bolster the immune system as

radiation exposure can cause immunosuppression. Current deficiencies include a need for FDA-

approved therapeutics and countermeasures to treat radiological effects.

Projected Near/Mid-Term Capabilities and Deficiencies

No changes in capability are projected in the near/mid term for this task, so the overall projected

near/mid-term capability will remain “yellow.”

Projected Far-Term Capabilities and Deficiencies

No changes in capability are projected in the far term for this task, so the overall projected far-

term capability will remain “yellow.”

For Official Use Only

For Official Use Only

CBRND Functional Needs Analysis/Functional Solution Analysis

Chapter 17. Tactical Sustain Tasks

Table 17.10-1. TASUST 10: Capabilities and Deficiencies Assessment

System/Measure

Current

Radiological Exposure Therapeutics and Supportive Care

Current and Overall Capabilities

Near/Mid-Term Overall Capabilities

Far-Term Overall Capabilities

FAA Measure

Elaboration

Scale

Therapeutics are

10: FDA approved for use in both personnel and MWAs.

FDA approved?

5: Not FDA approved in personnel and/or MWAs; can be used

“extra label” for personnel and/or MWAs.

0: Not FDA approved in either personnel or MWAs; cannot be used

“extra label” for personnel and/or MWAs.

Therapeutics exist

Effectiveness of a particular therapeutic for radiological

10: Complete capability (effective for all radiological hazards).

for all radiological

hazards of a certain type (i.e., alpha emitters, beta emitters,

5: Partial capability (limited effectiveness for one or more

hazards?

gamma emitters, neutron emitters; alpha radiation, beta

radioisotope internalizations or radiation type exposures).

radiation, gamma radiation, neutron radiation).

0: No capability.

Capability

10: DOTLPF exists and is adequate for this task. Task can be

(DOTLPF) exists to

effectively performed with minor limitations with little or no direct

treat radiological

impact upon operations.

exposure?

5: Most critical aspects of DOTLPF for this task are addressed.

0: DOTLPF is inadequate or does not exist for this task. Task can

not be effectively accomplished.

For Official Use Only

CBRND Functional Needs Analysis/Functional Solution Analysis

Chapter 17. Tactical Sustain Tasks

17.10.3

Functional Solution Analysis

17.10.3.1

DOTLPF Assessment Summary

This section states the deficiencies and suggests potential non-materiel solutions. If there are no

solutions or there are only partial solutions for a particular deficiency, that deficiency is then

reassessed in the IMA section.

Deficiency: Lack of FDA-approved therapeutics and alternative therapeutic delivery systems

that are quick-acting, long-lasting, and easy to carry and use on the battlefield.

Non-Materiel Solutions: Leadership (partial): Obtain FDA-approval for therapeutics and

alternative therapeutic delivery systems

Deficiency: Lack of guidance of when INDs can be used to treat radiological effects.

Non-Materiel Solutions: Doctrine: Define those circumstances when use of INDs can be

considered to treat radiological effects.

Deficiency: Significant toxic effects of therapeutics such as chelating agents.

Non-Materiel Solutions: None.

Deficiency: Lack of ability to evacuate casualties in a timely manner to level of care that can

provide definitive care.

Non-Materiel Solutions: Doctrine: Define theater evacuation policy to maximize evacuation

of casualties within critical time frame that will ensure casualties receive definitive medical

care.

Deficiency: Lack of animal model for current therapeutic initiatives.

Non-Materiel Solutions: Doctrine: Perform necessary animal model testing to create

doctrinal animal model for therapeutic initiatives.

Deficiency: Lack of drugs to prevent onset of radiation-induced performance decrements.

Non-Materiel Solutions: None.

17.10.3.2

IMA Assessment Summary

Table 17.10-2 identifies which of the materiel approaches might address specific materiel gaps

identified in the DOTMLPF assessment.

For Official Use Only

CBRND Functional Needs Analysis/Functional Solution Analysis

Chapter 17. Tactical Sustain Tasks

17.11 Task TASUST 11: Decontaminate individual and crew-served weapons

17.11.1

Functional Area Analysis

17.11.1.1

Definition

To decontaminate individual and crew-served weapons such as the 9-mm hand gun; M-16 rifle;

M60 machine gun; M203 grenade launcher; tube-launched, optically tracked, wire-guided

(TOW) missile; 81-mm mortar; M198 howitzer; etc. Includes minimizing effects of

contaminants and decontaminants on operations. Levels of decontamination include immediate,

operational, and thorough. Objectives of each of these levels are identified as follows:

• Immediate: Reduce/limit the spread of CBRN contamination.

• Operational: Reduce CBRN contamination to regenerate combat effectiveness.

• Thorough: Reduce CBRN contamination to negligible risk.

17.11.1.2

Derivation

UJTL (TA 7, TA 7.1), Protection Joint Functional Concept.

17.11.1.2.1

Supported Tasks: OPSUST 8, OPSUST 11

17.11.1.2.2

Lateral Task: TASHA 24

17.11.1.2.3

Supporting Task: N/A

17.11.1.3

Condition

Perform this task under conditions of:

Physical

1. Extremely rough sea state. (C1.2.1.3)

2. Tropical, arctic, and arid climate. (C1.3.1)

3. All seasons. (C1.3.1.1)

4. Precipitating and stormy weather. (C1.3.1.3)

5. Hot and very cold air temperature. (C1.3.1.3.1)

6. Liquid, freezing, and frozen precipitation. (C1.3.1.3.6.1)

7. Negligible light. (C1.3.2.1)

8. Nuclear effects. (C1.3.3.1)

9. Chemical effects. (C1.3.3.2)

10. Biological effects. (C1.3.3.3)

Military

1. Stressful mission. (C2.1)

2. Location—ashore/afloat. (C2.1.4.1)

For Official Use Only

CBRND Functional Needs Analysis/Functional Solution Analysis

Chapter 17. Tactical Sustain Tasks

3. Minimal to short time available. (C2.1.5)

4. Marginal forces allocated. (C2.2.3)

5. Low personnel capability. (C2.2.4)

6. Negligible personnel experience. (C2.2.4.5)

7. Severe personnel fatigue. (C2.2.4.6)

8. Limited, little, or no lift assets. (C2.5.2)

9. Some or no interoperability. (C2.2.6)

10. Limited or no host-nation support. (C2.8.5)

11. Ambiguous threat existence. (C2.9.3)

Civil

1. Limited or negative foreign government support. (C3.1.2.3)

2. Aggressively opposed foreign public opinion. (C3.1.2.4)

17.11.2

Functional Needs Analysis

17.11.2.1

Capabilities and Deficiencies Assessment Summary

Table 17.11-1 presents individual and overall current, near-/mid-term, and far-term capabilities

to perform the task to the designated standard. There are a total of four current capabilities used

to accomplish this task and three projected capabilities to be added in the future. Capabilities

exist at the immediate, operational, and thorough levels of decontamination.

Current Capabilities and Deficiencies

Current capabilities to decontaminate individual and crew-served weapons require the use of

M291/M295 kits, M100 SDS, soap and water, solvents and STB/HTH bleach mixtures.

Capability gaps associated with individual and crew-served weapons decontamination include

the excessive amount of time it takes to manually process large quantities of weapons through

thorough decontamination processes. STB and HTH decontaminants can be toxic and corrosive

requiring large amounts of water for dilution. Runoff from decontamination sites may be

contaminated and current decontaminants are only effective against a limited range of chemical

and biological agents. In addition, current thorough decontamination processes may not be

feasible in many operational situations due to time and space requirements.

Projected Near/Mid-Term Capabilities and Deficiencies

The projected near/mid-term capabilities and deficiencies evaluated were associated with JSPDS

Increment I and JSTDS-SS Increment I.

Projected Far-Term Capabilities and Deficiencies

The projected far-term capabilities and deficiencies evaluated were associated with JSPDS

Increment II, JSTDS-SS Increment II and JPDS Increments I/II.

For Official Use Only

For Official Use Only

CBRND Functional Needs Analysis/Functional Solution Analysis

Chapter 17. Tactical Sustain Tasks

Table 17.11-1. TASUST 11: Capabilities and Deficiencies Assessment

M10

M11

Capabilities

Current

M291/M295

N//

7¹

3²

1³

N/A

7⁴

N/A

8⁵

1⁶

9⁷

8⁸

7⁹

N/A

7¹⁰

Kits/ Exterior

M100 SDS

N/A

Hot Soapy

3¹¹

N/A

0¹²

4¹³

3¹⁴

5¹⁵

N/A

7¹⁶

5¹⁷

1¹⁸

N/A

Water

HTH/STB

N/A

5¹⁹

N/A

Near/Mid-Term

JSPDS

9²⁰

N/A

Increment I

JSTDS-SS

N/A

2²¹

N/A

Increment I

Far-Term

JSPDS

5²²

N/A

10²³

Increment II

JSTDS-SS

10²⁴

N/A

8²⁵

10²⁶

N/A

Increment II

JPDS

Increment I/II

Current

Overall

5²⁷

4²⁸

Capabilities

Near/Mid-

Term Overall

Capabilities

Far-Term

Overall

6²⁹

Capabilities

FAA Measure

Elaboration

Scale

(Yes/No) Contaminated by-

The by-products from the

10: Yes, Complete (100%).

products are controlled?

decontamination process are controlled.

7: Yes, Substantial (~75%).

Where the control of by-products is less

5: Yes, Partial (~50%).

than 100%, measures must be in place

3: Yes, Minimal (~25%).

to prevent by-products from becoming

0: No, Contaminated by-products cannot be controlled and present an

an unacceptable hazard.

unacceptable hazard.

100

For Official Use Only

CBRND Functional Needs Analysis/Functional Solution Analysis

Chapter 17. Tactical Sustain Tasks

(Level) Of chemical

The level of chemical contamination is

10: Decontaminate all CWAs, NTAs, TIMs to general population exposure

contamination after

acceptable after decontamination

limits.

decontamination procedures.

operations from a starting liquid

7: Decontaminate all CWAs, all NTAs, and some TIMs to a level that will

challenge of 10 g/m². Agents defined

allow unprotected exposure.

as current-generation CWAs, NTAs,

5: Decontaminate all CWAs, some NTAs to a level that will allow

TIMs, and TICs.

unprotected exposure.

3: Decontaminate most CWAs to a level that will allow unprotected

exposure.

0: No effective decontaminant or process.

(Level) Of biological

The level of biological contamination is

10: 0 CFU/PFU/m²—total removal or neutralization of toxins against all 25

contamination after

acceptable after decontamination

threat agents.

decontamination procedures.

procedures. Vegetative and

9: 0 CFU/PFU/m²—total removal or neutralization of toxins against 20 or

nonvegetative bacteria are measured in

more key threat agents.

CFU/m², and viruses are measured in

8: 0 CFU/PFU/m²—total removal or neutralization of toxins against 15 or

PFU/m².

more key threat agents.

7: 0 CFU/PFU/m²—total removal or neutralization of toxins against 10 or

more key threat agents.

6: 0 CFU/PFU/m²—total removal or neutralization of toxins against eight

or more key threat agents.

5: Less than infective dose levels/casualty-producing toxin exposure levels

against six or more key threat agents.

4: Less than infective dose levels/casualty-producing toxin exposure levels

against four key threat agents.

3: Less than infective dose levels/casualty-producing toxin exposure levels

against three key threat agents.

2: Less than infective dose levels/casualty-producing toxin exposure levels

against two or more key threat agents.

1: Less than infective dose levels/casualty-producing toxin levels against

one key threat agent.

0: More than infective dose levels/casualty-producing toxin exposure

levels.

101

For Official Use Only

CBRND Functional Needs Analysis/Functional Solution Analysis

Chapter 17. Tactical Sustain Tasks

(Level) Of radiological

The level of radiological contamination

10: Total removal to natural backg1round level.

contamination after

is acceptable after decontamination

8: ≤0.11 cGy/hour residual dose rate.

decontamination procedures.

operations from a starting challenge of

6: ≤0.22 cGy/hour residual dose rate.

4 g/m² of insoluble radioactive

4: <0.33 cGy/hour residual dose rate.

contaminants, 37-200 μm in size and

2: 0.33 cGy/hour residual dose rate 0.

185 GBq/m² gamma activity.

0: Removal capabilities limited or ineffective, allowing excessive residual

0.33 cGy/hour equates to an exposure

dose rates >0.33 cGy/hour.

that can cause mild incapacitation in

2.5% or less of unprotected, not

previously exposed personnel.

(Yes/No) Cross-

Cross-contamination is controlled.

10: Yes, Complete (100%).

contamination is controlled?

Where contaminated by-products are

7: Yes, Substantial (~75%).

less than 100% controlled, measures

5: Yes, Partial (~50%).

must be in place to prevent cross-

3: Yes, Minimal (~25%).

contamination from becoming an

0: No, cross-contamination cannot be controlled and present an

unacceptable hazard

unacceptable hazard.

(Time) To initiate and

Initiate and complete immediate

Immediate

Operational

conduct immediate and

weapon decontamination procedures in

10: Immediately

10: >300

operational decontamination

minimal amount of time.

9: <1 minute

9: 250-300

procedures.

8: <2 minutes

8: 200-249

Number of weapons that can be

7: <3 minutes

7: 160-199

operationally decontaminated per hour.

6: <4 minutes

6: 120-159

5: <5 minutes

5: 100-119

4: <7 minutes

4: 80-99

3: <9 minutes

3: 60-79

2: <12 minutes

2: 40-59

1: <15 minutes

1: 20-39

0: >15 minutes

0: <20

(Percent) Of systems

The quantity of systems that may be

10: 0%

unusable due to the effects

rendered unserviceable by

9: <1%

of decontamination.

decontamination process must be

8: <2%

minimized.

7: <3%

6: <4%

5: <5%

4: <6%

3: <7%

2: <8%

1: <9%

0: ≥10%

102

For Official Use Only

CBRND Functional Needs Analysis/Functional Solution Analysis

Chapter 17. Tactical Sustain Tasks

(Percent) Of systems that

The quantity of repairs or parts

10: 0%

require repair or replacement

replacements required due to

9: <1%

due to the effects of

decontamination process must be

8: <2%

decontamination.

minimized.

7: <3%

6: <4%

5: <5%

4: <6%

3: <7%

2: <8%

1: <9%

0: ≥10%

(Yes/No) Decontamination

Decontamination procedures must be

10: No negative impacts on operations.

procedures are logistically

logistically supportable.

7: Limited negative impact on operational capability.

supportable?

5: Moderate negative impact on operational capability.

3: Major negative impact on operational capability.

0: Not logistically supportable.

M10

(Time) To conduct thorough

Number of weapons that can be

10: >150

decontamination procedures.

thoroughly decontaminated per hour.

9: 125-150

8: 100-124

7: 80-99

6: 60-79

5: 50-59

4: 40-49

3: 30-39

2: 20-29

1: 10-19

0: <10

M11

There is effective DOTLPF

Refers to non-materiel elements

10: DOTLPF is adequate for all tasks to be performed with this system

in place to conduct task?

associated with the execution of a task

without limitations that cause significant impact upon operations.

with the system.

7: DOTLPF is adequate for most of the tasks to be performed with this

system without limitations that cause significant impact upon operations.

5: Many critical aspects of DOTLPF for the task to be performed with this

system are addressed.

3: Some critical aspects of DOTLPF for the task to be performed with this

system are addressed.

0: DOTLPF is completely inadequate or does not exist for the tasks to be

performed with this system.

¹ M1 - (Yes/No) Contaminated by-products are controlled? 7: Yes, Substantial (~75%).

² M2 - (Level) Of chemical contamination after decontamination procedures. 3: Decontaminate most CWAs to a level that will allow unprotected exposure.

103

For Official Use Only

CBRND Functional Needs Analysis/Functional Solution Analysis

Chapter 17. Tactical Sustain Tasks

³ M3 - (Level) Of biological contamination after decontamination procedures. 1: Less than infective dose levels/casualty-producing toxin levels against one key threat agent.

⁴ M5 - (Yes/No) Cross-contamination is controlled? 7: Yes, Substantial (~75%).

⁵ M6 - (Time) To initiate and conduct immediate decontamination procedures. 8: <2 minutes.

⁶ M6 - (Time) To initiate and conduct operational decontamination procedures. 1: 20-39 weapons can be operationally decontaminated per hour.

⁷ M7 - (Percent) Of systems unusable due to the effects of decontamination. 9: <1%.

⁸ M8 - (Percent) Of systems that require repair or replacement due to the effects of decontamination. 8: <2%.

⁹ M9 - (Yes/No) Decontamination procedures are logistically supportable? 7: Limited negative impact on operational capability.

¹⁰ M11 - There is effective DOTLPF in place to conduct task? 7: DOTLPF is adequate for most of the tasks to be performed with this system without limitations that cause

significant impact upon operations.

¹¹ M1 - (Yes/No) Contaminated by-products are controlled? 3: Yes, Minimal (~25%).

¹² M2 - (Level) Of chemical contamination after decontamination procedures. 0: No effective decontaminant or process.

¹³ M4 - (Level) Of radiological contamination after decontamination procedures. 4: <0.33 cGy/hour residual dose rate.

¹⁴ M5 - (Yes/No) Cross-contamination is controlled? 3: Yes, Minimal (~25%).

¹⁵ M5 - (Yes/No) Cross-contamination is controlled? 5: Yes, Partial (~50%).

¹⁶ M8 - (Percent) Of systems that require repair or replacement due to the effects of decontamination. 7: <3%.

¹⁷ M9 - (Yes/No) Decontamination procedures are logistically supportable? 5: Moderate negative impact on operational capability.

¹⁸ M10 - (Time) To conduct thorough decontamination procedures. 1: 10-19 weapons can be thoroughly decontaminated per hour.

¹⁹ M3 - (Level) Of biological contamination after decontamination procedures. 5: Less than infective dose levels/casualty-producing toxin-exposure levels against six or more key

threat agents.

²⁰ M6 - (Time) To initiate and conduct immediate decontamination procedures. 9: <1 minute.

²¹ M10 - (Time) To conduct thorough decontamination procedures. 2: 20-29 weapons can be thoroughly decontaminated per hour.

²² M2 - (Level) Of chemical contamination after decontamination procedures. 5: Decontaminate all CWAs, some NTAs to a level that will allow unprotected exposure.

²³ M11 - There is effective DOTLPF in place to conduct task? 10: DOTLPF is adequate for all tasks to be performed with this system without limitations that cause significant

impact upon operations.

²⁴ M1 - (Yes/No) Contaminated by-products are controlled? 10: Yes, Complete (100%).

²⁵ M4 - (Level) Of radiological contamination after decontamination procedures. 8: ≤0.11 cGy/hour residual dose rate.

²⁶ M5 - (Yes/No) Cross-contamination is controlled? 10: Yes, Complete (100%).

²⁷ M1 - (Yes/No) Contaminated by-products are controlled? 5: Yes, Partial (~50%).

²⁸ M3 - (Level) Of biological contamination after decontamination procedures. 4: Less than infective dose levels/casualty-producing toxin-exposure levels against four key threat

agents.

²⁹ M4 - (Level) Of radiological contamination after decontamination procedures. 6: <0.22 cGy/hour residual dose rate.

104

For Official Use Only

CBRND Functional Needs Analysis/Functional Solution Analysis

Chapter 17. Tactical Sustain Tasks

17.11.3 Functional Solution Analysis

17.11.3.1.

DOTLPF Assessment Summary

This section states the deficiencies and suggests potential non-materiel solutions. If there are no

solutions or there are only partial solutions for a particular deficiency, the deficiency is then

reassessed in the IMA section.

Current capabilities to decontaminate individual and crew-served weapons require using M291/

M295 kits, M100 SDS, soap and water, and STB/HTH bleach mixtures. Capability gaps associated

with individual and crew-served weapons decontamination include the excessive amount of time it

takes to manually process large quantities of weapons through thorough decontamination

processes, STB and HTH decontaminants can be toxic and corrosive requiring water for dilution,

runoff from decontamination sites may be contaminated, and runoff must be controlled.

Deficiency: Current decontaminants are effective against only a limited range of chemical

and biological agents.

Non-Materiel Solutions: None.

Deficiency: Risk of damage to sensitive parts.

Non-Materiel Solutions: Doctrine (partial): Modify doctrine to ensure applicable

decontaminants are used on sensitive equipment.

Deficiency: Runoff may be contaminated.

Partial Non-Materiel Solutions: Doctrine (partial): Modify doctrine to consider

contaminated runoff as an operational consideration. Doctrine should address how to dispose

of or neutralize runoff. Training (partial): Modify training to consider contaminated runoff

as an operational consideration. Training should address how to dispose of or neutralize

runoff.

Deficiency: The inability to decontaminate porous materiel.

Non-Materiel Solutions: None.

Deficiency: Large amounts of water are required to support current decontamination processes.

Non-Materiel Solutions: None.

Deficiency: Current thorough decontamination processes may not be feasible in many

operational situations due to time and space requirements.

Non-Materiel Solutions: None.

Deficiency: Powder from sorbent-based (M291/M295/M100) decontamination kits can cause

weapons malfunctions.

Non-Materiel Solutions: Training: Proper training on weapons decontamination and

associated post-decontamination maintenance.

105

For Official Use Only

CBRND Functional Needs Analysis/Functional Solution Analysis

Chapter 17. Tactical Sustain Tasks

17.12 Task TASUST 12: Decontaminate vehicles, weapons, and nonsensitive equipment

17.12.1

Functional Area Analysis

17.12.1.1

Definition

To decontaminate ground vehicles and hardened equipment, such as tanks, high-mobility

multipurpose wheeled vehicles, commercial utility cargo vehicles, 5-ton trucks, materiel-

handling equipment, ground support equipment, etc. Includes minimizing effects of

contaminants and decontaminants on operations. Levels of decontamination include immediate,

operational, and thorough. Objectives of each of these levels are identified as follows:

• Immediate: Limit spread of contamination.

• Operational: Gross removal of exterior contamination.

• Thorough: Reduce contamination to negligible levels.

17.12.1.2

Derivation

UJTL (TA 7, TA 7.1), Protection Joint Functional Concept.

17.12.1.2.1

Supported Tasks: OPSUST 8, OPSUST 11

17.12.1.2.2

Lateral Task: TASHA 24

17.12.1.2.3

Supporting Task: N/A

17.12.1.3

Condition

Perform this task under conditions of:

Physical

1. Extremely rough sea state. (C1.2.1.3)

2. Tropical, arctic, and arid climate. (C1.3.1)

3. All seasons. (C1.3.1.1)

4. Precipitating and stormy weather. (C1.3.1.3)

5. Hot and very cold air temperature. (C1.3.1.3.1)

6. Liquid, freezing, and frozen precipitation. (C1.3.1.3.6.1)

7. Negligible light. (C1.3.2.1)

8. Nuclear effects. (C1.3.3.1)

9. Chemical effects. (C1.3.3.2)

10. Biological effects. (C1.3.3.3)

Military

1. Stressful mission. (C2.1)

2. Location—ashore/afloat. (C2.1.4.1)

108

For Official Use Only

CBRND Functional Needs Analysis/Functional Solution Analysis

Chapter 17. Tactical Sustain Tasks

3. Minimal to short time available. (C2.1.5)

4. Marginal forces allocated. (C2.2.3)

5. Some or no interoperability. (C2.2.6)

6. Low personnel capability. (C2.2.4)

7. Negligible personnel experience. (C2.2.4.5)

8. Severe personnel fatigue. (C2.2.4.6)

9. Limited, little, or no lift assets. (C2.5.2)

10. Limited or no host-nation support. (C2.8.5)

11. Ambiguous threat existence. (C2.9.3)

Civil

1. Limited or negative foreign government support. (C3.1.2.3)

2. Aggressively opposed foreign public opinion. (C3.1.2.4)

3. High mission priority. (C3.1.3.2)

17.12.2

Functional Needs Analysis

17.12.2.1

Capabilities and Deficiencies Assessment Summary

Table 17.12-1 present individual and overall current, near-/mid-term, and far-term capabilities to

perform the task to the designated standard. There are a total of four current capabilities used to

accomplish this task and four projected capabilities to be added in the future. Capabilities exist at

the immediate, operational, and thorough levels of decontamination.

Current Capabilities and Deficiencies

The most current capabilities associated with vehicles, along with vehicle-mounted weapons and

nonsensitive equipment include a variety of decontaminants such as soap and water, STB, and

HTH, along with appropriate applicators. However, there are minimal capabilities to

decontaminate vehicle interiors, particularly if porous material is involved. Primary deficiencies

include the potential damage to vehicles, weapons, and nonsensitive equipment surfaces with the

use of corrosive decontaminants, as well as dangerous chemical reactions occurring with the

combination of certain decontaminants. Other deficiencies include the requirement for large

amounts of water, time, and personnel; controlling contaminated runoff; and the inability to

decontaminate porous materials.

Projected Near/Mid-Term Capabilities and Deficiencies

The projected near/mid-term capabilities and deficiencies evaluated were associated with JSPDS

Increment I, JSTDS-SS Increment I and JPID Increment I.

Projected Far-Term Capabilities and Deficiencies

The projected far-term capabilities and deficiencies evaluated were associated with JSTDS-SS

Increment II, JSTDS-LS Increments I and II, JPID Increment II, and JPDS Increments I and II.

109

For Official Use Only

For Official Use Only

CBRND Functional Needs Analysis/Functional Solution Analysis

Chapter 17. Tactical Sustain Tasks

Table 17.12-1. TASUST 12: Capabilities and Deficiencies Assessment

M10

M11

M12

Capabilities

Current

HTH/STB

5¹

3²

5³

3⁴

5⁵

8⁶

9⁷

7⁸

5⁹

0¹⁰

7¹¹

M291/M295

Kits/Spot

7¹²

1¹³

7¹⁴

8¹⁵

9¹⁶

7¹⁷

8¹⁸

7¹⁹

N/A

Cleaning

M100

SDS/Spot

N/A

Cleaning

Hot Soapy

0²⁰

3²¹

4²²

1²³

Water

Near/Mid-Term

JSTDS-SS

1²⁴

Increment I

JPID

7²⁵

7²⁶

9²⁷

5²⁸

0²⁹

Increment I

JSPDS

6³⁰

N/A

Increment I

Far-Term

JSTDS-SS

10³¹

5³²

8³³

10³⁵

4³⁶

6³⁷

10³⁸

Increment II

JSTDS-LS

Increment I/II

JPDS

Increment I/II

JPID

Increment II

Current

Overall

Capabilities

Near/Mid-

Term Overall

Capabilities

Far-Term

Overall

Capabilities

110

For Official Use Only

CBRND Functional Needs Analysis/Functional Solution Analysis

Chapter 17. Tactical Sustain Tasks

FAA Measure

Elaboration

Scale

(Yes/No) Contaminated by-products

Contaminated by-products are controlled.

10: Yes, Complete (100%).

are controlled?

Where by-products are less than 100%

7: Yes, Substantial (~75%).

controlled, measures must be in place to

5: Yes, Partial (~50%).

prevent cross-contamination from becoming

3: Yes, Minimal (~25%).

an unacceptable hazard.

0: No, Contaminated by-products cannot be controlled and

present an unacceptable hazard.

(Level) Of chemical contamination

The level of chemical contamination is

10: Decontaminate all CWAs, NTAs, TIMs to general

after decontamination procedures.

acceptable after decontamination operations

population exposure limits.

from a starting liquid challenge of 10 g/m².

7: Decontaminate all CWAs, all NTAs, and some TIMs to a

Agents defined as current-generation CWAs,

level that will allow unprotected exposure.

NTAs, TIMs, and TICs.

5: Decontaminate all CWAs, some NTAs to a level that will

allow unprotected exposure.

3: Decontaminate most CWAs to a level that will allow

unprotected exposure.

0: No effective decontaminant or process.

(Level) Of biological contamination

The level of biological contamination is

10: 0 CFU/PFU/m²—total removal or neutralization of

after decontamination procedures.

acceptable after decontamination procedures.

toxins against all 25 threat agents.

Vegetative and nonvegetative bacteria are

9: 0 CFU/PFU/m²—total removal or neutralization of toxins

measured in CFU/m² and viruses are

against 20 or more key threat agents.

measured in PFU/m².

8: 0 CFU/PFU/m²—total removal or neutralization of toxins

against 15 or more key threat agents.

7: 0 CFU/PFU/m²—total removal or neutralization of toxins

against 10 or more key threat agents.

6: 0 CFU/PFU/m²—total removal or neutralization of toxins

against eight or more key threat agents.

5: Less than infective dose levels/casualty-producing toxin

exposure levels against six or more threat agents.

4: Less than infective dose levels/casualty-producing toxin

exposure levels against four key threat agents.

3: Less than infective dose levels/casualty-producing toxin

exposure levels against three key threat agents.

2: Less than infective dose levels/casualty-producing toxin

exposure levels against two or more key threat agents.

1: Less than infective dose levels/casualty-producing toxin

levels against one key threat agent.

0: More than infective dose levels/casualty-producing toxin

exposure levels.

111

For Official Use Only

CBRND Functional Needs Analysis/Functional Solution Analysis

Chapter 17. Tactical Sustain Tasks

(Level) Of radiological

The level of radiological contamination is

10: Total removal to natural backg1round level.

contamination after decontamination

acceptable after decontamination operations

8: ≤0.11 cGy/hour residual dose rate.

procedures.

from a starting challenge of 4 g/m² of

6: ≤0.22 cGy/hour residual dose rate.

insoluble radioactive contaminants, 37-200

4: <0.33 cGy/hour residual dose rate.

μm in size and 185 GBq/m²gamma activity.

2: 0.33 cGy/hour residual dose rate.

0.33 cGy/hour equates to an exposure that can

0: Removal capabilities limited or ineffective, allowing

cause mild incapacitation in 2.5% or less of

excessive residual dose rates >0.33 cGy/hour.

unprotected, not previously exposed

personnel.

(Yes/No) Cross-contamination is

Cross-contamination is controlled. Where

10: Complete (100%).

controlled?

cross-contamination is less than 100%

7: Substantial (~75%).

controlled, measures must be in place to

5: Partial (~50%).

prevent cross-contamination from becoming

3: Minimal (~25%).

an unacceptable hazard.

0: No, cross-contamination cannot be controlled and present

an unacceptable hazard.

(Time) To initiate immediate and

Initiate immediate decontamination

Immediate

Operational

operational decontamination

procedures within a minimal amount of time.

10: Immediately

procedures.

9: <10 seconds

9: <1 hour

Initiate operational decontamination

8: <30 seconds

8: <2 hours

procedures within a minimal amount of time.

7: <45 seconds

7: <3 hours

6: <1 minute

6: <4 hours

5: <1 minute, 15 seconds

5: <5 hours

4: <1 minute, 30 seconds

4: <6 hours

3: <1 minute, 45 seconds

3: <7 hours

2: <2 minutes

2: <8 hours

1: <3 minutes

1: <9 hours

0: >3 minutes

0: >9 hours

(Time) To conduct immediate and

Complete immediate decontamination

Immediate

Operational

operational decontamination

procedures within a minimal amount of time.

10: Immediately

10: >100

procedures.

9: <1 minute

9: 90-100

Number of vehicles/other large equipment

8: <2 minutes

8: 80-89

items operationally decontaminated in one

7: <3 minutes

7: 70-79

hour.

6: <4 minutes

6: 60-69

5: <5 minutes

5: 50-59

4: <7 minutes

4: 40-49

3: <9 minutes

3: 30-39

2: <12 minutes

2: 20-29

1: <15 minutes

1: 10-19

0: >15 minutes

0: <10

112

For Official Use Only

CBRND Functional Needs Analysis/Functional Solution Analysis

Chapter 17. Tactical Sustain Tasks

(Percent) Of systems unusable due to

The quantity of systems that may be rendered

10: 0%

the effects of decontamination.

unserviceable by decontamination process

9: <1%

must be minimized.

8: <2%

7: <3%

6: <4%

5: <5%

4: <6%

3: <7%

2: <8%

1: <9%

0: ≥10%

(Percent) Of systems that require

The quantity of repairs or parts replacements

10: 0%

repair or replacement due to the

required due to decontamination process must

9: <1%

effects of decontamination.

be minimized.

8: <2%

7: <3%

6: <4%

5: <5%

4: <6%

3: <7%

2: <8%

1: <9%

0: ≥10%

M10

(Yes/No) Decontamination

Decontamination procedures must be

10: No negative impacts on operations.

procedures are logistically

logistically supportable.

7: Limited negative impact on operational capability.

supportable?

5: Moderate negative impact on operational capability.

3: Major negative impact on operational capability.

0: Not logistically supportable.

M11

(Quantity) Vehicles, weapons, and

Number of vehicles/other large equipment

10: >50

nonsensitive equipment

items thoroughly decontaminated in one hour

9: 45-49

decontaminated per hour.

8: 40-44

7: 35-39

6: 30-34

5: 25-29

4: 20-24

3: 15-19

2: 10-14

1: 5-9

0: <5

113

For Official Use Only

CBRND Functional Needs Analysis/Functional Solution Analysis

Chapter 17. Tactical Sustain Tasks

M12

There is effective DOTLPF in place

Refers to non-materiel elements associated

10: DOTLPF is adequate for all tasks to be performed with

to conduct task?

with the execution of a task with the system.

this system without limitations that cause significant impact

upon operations.

7: DOTLPF is adequate for most of the tasks to be performed

with this system without limitations that cause significant

impact upon operations.

5: Many critical aspects of DOTLPF for the task to be

performed with this system are addressed.

3: Some critical aspects of DOTLPF for the task to be

performed with this system are addressed.

0: DOTLPF is completely inadequate or does not exist for the

tasks to be performed with this system.

¹ M1 - (Yes/No) Contaminated by-products are controlled? 5: Yes, Partial (~50%).

² M2 - (Level) Of chemical contamination after decontamination procedures. 3: Decontaminate most CWAs to a level that will allow unprotected exposure.

³ M3 - (Level) Of biological contamination after decontamination procedures. 5: Less than infective dose levels/casualty-producing toxin-exposure levels against six or more

threat agents.

⁴ M5 - (Yes/No) Cross-contamination is controlled? 3: Minimal (~25%).

⁵ M5 - (Yes/No) Cross-contamination is controlled? 5: Partial (~50%).

⁶ M6 - (Time) To initiate operational decontamination procedures. 8: <2 hours.

⁷ M8 - (Percent) Of systems unusable due to the effects of decontamination. 9: <1%.

⁸ M9 - (Percent) Of systems that require repair or replacement due to the effects of decontamination. 7: <3%.

⁹ M10 - (Yes/No) Decontamination procedures are logistically supportable? 5: Moderate negative impact on operational capability.

¹⁰ M11 - (Quantity) Vehicles, weapons, and nonsensitive equipment decontaminated per hour. 0: <5.

¹¹ M12 - There is effective DOTLPF in place to conduct task? 7: DOTLPF is adequate for most of the tasks to be performed with this system without limitations that cause

significant impact upon operations.

¹² M1 - (Yes/No) Contaminated by-products are controlled? 7: Yes, Substantial (~75%).

¹³ M3 - (Level) Of biological contamination after decontamination procedures. 1: Less than infective dose levels/casualty-producing toxin levels against one key threat agent.

¹⁴ M5 - (Yes/No) Cross-contamination is controlled? 7: Substantial (~75%).

¹⁵ M6 - (Time) To initiate immediate decontamination procedures. 8: <30 seconds.

¹⁶ M6 - (Time) To initiate operational decontamination procedures. 9: <1 hour.

¹⁷ M7 - (Time) To conduct immediate decontamination procedures. 7: <3 minutes.

¹⁸ M9 - (Percent) Of systems that require repair or replacement due to the effects of decontamination. 8: <2%.

¹⁹ M10 - (Yes/No) Decontamination procedures are logistically supportable? 7: Limited negative impact on operational capability.

²⁰ M2 - (Level) Of chemical contamination after decontamination procedures. 0: No effective decontaminant or process.

²¹ M3 - (Level) Of biological contamination after decontamination procedures. 3: Less than infective dose levels/casualty-producing toxin-exposure levels against three key threat

agents.

²² M4 - (Level) Of radiological contamination after decontamination procedures. 4: <0.33 cGy/hour residual dose rate.

²³ M7 - (Time) To conduct operational decontamination procedures. 1: 10-19 vehicles/other large equipment items operationally decontaminated in one hour.

²⁴ M11 - (Quantity) Vehicles, weapons, and nonsensitive equipment decontaminated per hour. 1: 5-9.

²⁵ M3 - (Level) Of biological contamination after decontamination procedures. 7: 0 CFU/PFU/m²—total removal or neutralization of toxins against 10 or more key threat agents.

²⁶ M5 - (Yes/No) Cross-contamination is controlled? 7: Substantial (~75%).

²⁷ M6 - (Time) To initiate immediate decontamination procedures. 9: <10 seconds.

114

For Official Use Only

CBRND Functional Needs Analysis/Functional Solution Analysis

Chapter 17. Tactical Sustain Tasks

²⁸ M7 - (Time) To conduct immediate decontamination procedures. 5: <5 minutes.

²⁹ M7 - (Time) To conduct operational decontamination procedures. 0: <10 vehicles/other large equipment items operationally decontaminated in one hour.

³⁰ M7 - (Time) To conduct operational decontamination procedures. 6: 60-69 vehicles/other large equipment items operationally decontaminated in one hour.

³¹ M1 - (Yes/No) Contaminated by-products are controlled? 10: Yes, Complete (100%).

³² M2 - (Level) Of chemical contamination after decontamination procedures. 5: Decontaminate all CWAs, some NTAs to a level that will allow unprotected exposure.

³³ M4 - (Level) Of radiological contamination after decontamination procedures. 8: <0.11 cGy/hour residual dose rate.

³⁴ M5 - (Yes/No) Cross-contamination is controlled? 10: Complete (100%)

³⁵ M6 - (Time) To initiate operational decontamination procedures. 10: Immediately.

³⁶ M7 - (Time) To conduct operational decontamination procedures. 4: 40-49 vehicles/other large equipment items operationally decontaminated in one hour.

³⁷ M11 - (Quantity) Vehicles, weapons, and nonsensitive equipment thoroughly decontaminated per hour. 6: 30-34.

³⁸ M12 - There is effective DOTLPF in place to conduct task? 10: DOTLPF is adequate for all tasks to be performed with this system without limitations that cause significant

impact upon operations.

115

For Official Use Only

CBRND Functional Needs Analysis/Functional Solution Analysis

Chapter 17. Tactical Sustain Tasks

17.12.3

Functional Solution Analysis

17.12.3.1

DOTLPF Assessment Summary

This section states the deficiencies and suggests potential non-materiel solutions. If there are no

solutions or there are only partial solutions for a particular deficiency, the deficiency is then

reassessed in the IMA section.

Deficiency: Some decontaminants used in current procedures are corrosive, including STB,

and HTH.

Non-Materiel Solutions: Doctrine (partial): Modify doctrine, policy, procedures, and TTPs

to address noncorrosive decontamination and emphasize for selected systems and materials.

Deficiency: Runoff may be contaminated.

Non-Materiel Solutions: Doctrine (partial): Modify doctrine to consider contaminated

runoff as an operational consideration. Doctrine should address how to dispose of or

neutralize runoff. Training (partial): Modify training to consider contaminated runoff as an

operational consideration. Training should address how to dispose of or neutralize runoff.

Facilities (partial): Supporting infrastructure to neutralize or dispose of captured

contaminated runoff.

Deficiency: Current decontaminants may not neutralize all hazards.

Non-Materiel Solutions: None.

Deficiency: Current operational and thorough procedures require large amounts of water.

Non-Materiel Solutions: Doctrine (partial): Modify existing doctrine, policy, and

procedures to address reduced water decontamination. Training (partial): Units should be

trained to recognize water requirements for decontamination operations, and plan

accordingly.

Deficiency: Operational and thorough procedures are manpower and equipment intensive.

Non-Materiel Solutions: Doctrine (partial): Modify doctrine to include proceduresfor

removing or replacing porous materials from vehicles. Training (partial): Modify

institutional and unit-level training to include reduced manpower and equipment

requirements for decontamination.

Deficiency: Inability to decontaminate porous materials.

Non-Materiel Solutions: Doctrine (partial): Modify doctrine to include procedures for

removing or replacing porous materials from vehicles.

Deficiency: Inability to decontaminate hard-to-reach places using current applicators.

Non-Materiel Solutions: None.

116

For Official Use Only

CBRND Functional Needs Analysis/Functional Solution Analysis

Chapter 17. Tactical Sustain Tasks

17.13 Task TASUST 13: Decontaminate sensitive equipment

17.13.1

Functional Area Analysis

17.13.1.1

Definition

To decontaminate equipment for command and control, communications and computers, along

with optic systems such as night vision goggles, infrared-imaging systems, laser spotting

devices, etc. Includes minimizing effects of contaminants and decontaminants on operations.

Sensitive equipment may be decontaminated individually or decontaminated as part of interior

decontamination if large and bulky or not readily removable from within a platform or facility.

Levels of decontamination include immediate, operational, and thorough. Objectives of each of

these levels are identified as follows:

• Immediate: Reduce contact hazard and limit spread of contamination.

• Operational: Gross removal of contamination.

• Thorough: Eliminate contamination prior to reissue or further use.

17.13.1.2

Derivation

UJTL (TA 7, TA 7.1), Protection Joint Functional Concept.

17.13.1.2.1

Supported Tasks: OPSUST 8, OPSUST 11

17.13.1.2.2

Lateral Task: TASHA 24

17.13.1.2.3

Supporting Task: N/A

17.13.1.3

Condition

Perform this task under conditions of:

Physical

1. Extremely rough sea state. (C1.2.1.3)

2. Tropical, arctic, and arid climate. (C1.3.1)

3. All seasons. (C1.3.1.1)

4. Precipitating and stormy weather. (C1.3.1.3)

5. Hot and very cold air temperature. (C1.3.1.3.1)

6. Liquid, freezing, and frozen precipitation. (C1.3.1.3.6.1)

7. Negligible light. (C1.3.2.1)

8. Nuclear effects. (C1.3.3.1)

9. Chemical effects. (C1.3.3.2)

10. Biological effects. (C1.3.3.3)

119

For Official Use Only

CBRND Functional Needs Analysis/Functional Solution Analysis

Chapter 17. Tactical Sustain Tasks

Military

1. Stressful mission. (C2.1)

2. Location—ashore/afloat/airborne. (C2.1.4.1)

3. Minimal to short time available. (C2.1.5)

4. Marginal forces allocated. (C2.2.3)

5. Low personnel capability. (C2.2.4)

6. Negligible personnel experience. (C2.2.4.5)

7. Limited, little, or no lift assets. (C2.5.2)

8. Some or no interoperability. (C2.2.6)

9. Limited or no host-nation support. (C2.8.5)

10. Ambiguous threat existence. (C2.9.3)

Civil

1. High mission priority. (C3.1.3.2)

17.13.2

Functional Needs Analysis

17.13.2.1

Capabilities and Deficiencies Assessment Summary

Table 17.13-1 presents individual and overall current, near-/mid-term, and far-term capabilities

to perform the task to the designated standard. There are a total of three current capabilities used

to accomplish this task and two projected capabilities to be added in the future. Capabilities exist

at the immediate, operational, and thorough levels of decontamination.

Current Capabilities and Deficiencies

There are limited capabilities to decontaminate electronics and optics using decontaminants such

as HTH, STB, soapy water, vacuums, pressurized air, and M291/M295 chemical

decontamination kits. Deficiencies include the potential damage to electronic and optical systems

with the use of corrosive decontaminants, as well as the inability to decontaminate circuit boards,

porous, and hard-to-reach surfaces. Also, in the case of biological hazards, some capabilities,

such as soap and water, may not remove all biological spores and may require a combination of

decontaminants and applied procedures.

Projected Near/Mid-Term Capabilities and Deficiencies

The projected near/mid-term capabilities and deficiencies evaluated were associated with JSSED

Increment I and JPID Increment I.

Projected Far-Term Capabilities and Deficiencies

The projected far-term capabilities and deficiencies evaluated were associated with JSSED

Increment II and JPID Increment II.

120

For Official Use Only

For Official Use Only

CBRND Functional Needs Analysis/Functional Solution Analysis

Chapter 17. Tactical Sustain Tasks

Table 17.13-1. TASUST 13: Capabilities and Deficiencies Assessment

M10

M11

M12

Capabilities

Current

M291/M295

7¹

3²

1³

N/A

7⁴

8⁵

8⁶

8⁷

5⁸

1⁹

0¹⁰

0¹¹

5¹²

1¹³

3¹⁴

Kits

Hot Soapy

3¹⁵

0¹⁶

3¹⁷

4¹⁸

3¹⁹

6²⁰

7²¹

3²²

Water

HTH/STB

5²³

5²⁴

N/A

5²⁵

N/A

Near/Mid-Term

JSSED

10²⁶

8²⁷

10²⁸

3²⁹

9³⁰

N/A

9³¹

2³²

10³³

Increment I

JPID

7³⁴

Increment I

Far-Term

JSSED

9³⁵

10³⁶

N/A

10³⁷

Increment II

JPID

Increment II

Current

Overall

3³⁸

Capabilities

Near/Mid-

Term

Overall

Capabilities

Far-Term

Overall

5³⁹

Capabilities

FAA Measure

Elaboration

Scale

(Yes/No) Contaminated by-

Contaminated by-products are

10: Yes, Complete (100%).

products are controlled?

controlled. Where by-products are

7: Yes, Substantial (~75%).

less than 100% controlled, measures

5: Yes, Partial (~50%).

must be in place to prevent by-

3: Yes, Minimal (~25%).

products from becoming an

0: No, Contaminated by-products cannot be controlled and present an unacceptable hazard.

unacceptable hazard.

121

For Official Use Only

CBRND Functional Needs Analysis/Functional Solution Analysis

Chapter 17. Tactical Sustain Tasks

(Level) Of chemical

The level of chemical contamination

10: Decontaminate all CWAs, NTAs, TIMs to general population exposure limits.

contamination after

is acceptable after decontamination

7: Decontaminate all CWAs, all NTAs, and some TIMs to a level that will allow unprotected

decontamination procedures.

operations from a starting liquid

exposure.

challenge of 1 g/m². Agents defined

5: Decontaminate all CWAs and some NTAs to a level that will allow unprotected exposure.

as current-generation CWAs, NTAs,

3: Decontaminate most CWAs to a level that will allow unprotected exposure.

TIMs, and TICs.

0: No effective decontaminant or process.

(Level) Of biological

The level of biological

10: 0 CFU/PFU/m²—total removal or neutralization of toxins against all 25 threat agents.

contamination after

contamination is acceptable after

9: 0 CFU/PFU/m²—total removal or neutralization of toxins against 20 or more key threat

decontamination procedures.

agents.

Vegetative and nonvegetative

8: 0 CFU/PFU/m²—total removal or neutralization of toxins against 15 or more key threat

bacteria are measured in CFU/m²,

agents.

and viruses are measured in

7: 0 CFU/PFU/m²—total removal or neutralization of toxins against 10 or more key threat

PFU/m².

agents.

6: 0 CFU/PFU/m²—total removal or neutralization of toxins against eight or more key threat

agents.

5: Less than infective dose levels/casualty-producing toxin exposure levels against six or more

key threat agents.

4: Less than infective dose levels/casualty-producing toxin exposure levels against four key

threat agents.

3: Less than infective dose levels/casualty-producing toxin exposure levels against three key

threat agents.

2: Less than infective dose levels/casualty-producing toxin exposure levels against two or more

key threat agents.

1: Less than infective dose levels/casualty-producing toxin levels against one key threat agent.

0: More than infective dose levels/casualty-producing toxin exposure levels.

(Level) Of radiological

The level of radiological

10: Total removal to natural backg1round level.

contamination after

contamination is acceptable after

8: ≤0.11 cGy/hour residual dose rate.

decontamination procedures.

decontamination operations from a

6: ≤0.22 cGy/hour residual dose rate.

starting challenge of 0.4 g/m² of

4: <0.33 cGy/hour residual dose rate.

insoluble radioactive contaminants,

2: 0.33 cGy/hour residual dose rate.

37200 μm in size and 185 GBq/m²

0: Removal capabilities limited or ineffective, allowing excessive residual dose rates

gamma activity. 0.33 cGy/hour

>0.33 cGy/hour.

equates to an exposure that can

cause mild incapacitation in 2.5% or

less of unprotected, not previously

exposed personnel.

(Yes/No) Cross-

Cross-contamination is controlled.

10: Yes, Complete (100%).

contamination is controlled?

Where cross-contamination is less

7: Yes, Substantial (~75%).

than 100% controlled, measures

5: Yes, Partial (~50%).

must be in place to prevent cross-

3: Yes, Minimal (~25%).

contamination from becoming an

0: No, Cross-contamination cannot be controlled and presents an unacceptable hazard.

unacceptable hazard.

122

For Official Use Only

CBRND Functional Needs Analysis/Functional Solution Analysis

Chapter 17. Tactical Sustain Tasks

(Time) To initiate

Initiate immediate decontamination

Immediate

Operational

Thorough

immediate, operational, and

procedures within adequate amount

10: Immediate

10 :Immediate

thorough decontamination

of time.

9: <10 seconds

9: 15 minutes

9: 30 minutes

procedures.

8: <30 seconds

8: 30 minutes

8: 45 minutes

Initiate operational decontamination

7: <45 seconds

7: 45 minutes

7: 1 hour

procedures within adequate amount

6: <1 minute

6: <1 hour

6: <2 hours

of time.

5: <1 minute, 15 seconds

5: <2 hours

5: <3 hours

4: <1 minute, 30 seconds

4: <3 hours

4: <4 hours

Initiate thorough decontamination

3: <1 minute, 45 seconds

3: <4 hours

3: <5 hours

procedures within adequate amount

2: <2 minutes

2: <5 hours

2: <6 hours

of time.

1: <3 minutes

1: <6 hours

1: <8 hours

0: >3 minutes

0: >6 hours

0: >8 hours

(Time) To conduct

Minimize time required to

10: Immediate

immediate, operational, and

decontaminate each sensitive

9: <1 minute

thorough decontamination

equipment item.

8: <2 minutes

procedures

7: <3 minutes

6: <4 minutes

5: <5 minutes

4: <6 minutes

3: <8 minutes

2: <10 minutes

1: <30 minutes

0: >30 minutes

(Percent) Of systems

The quantity of systems that may be

10: 0%

unusable due to the effects of

rendered unserviceable by

9: <1%

decontamination.

decontamination process must be

8: <2%

minimized.

7: <3%

6: <4%

5: <5%

4: <6%

3: <7%

2: <8%

1: <9%

0: ≥10%

123

For Official Use Only

CBRND Functional Needs Analysis/Functional Solution Analysis

Chapter 17. Tactical Sustain Tasks

(Percent) Of systems that

The quantity of repairs or parts

10: 0%

require repair or replacement

replacements required due to

9: <1%

due to the effects of

decontamination process must be

8: <2%

decontamination.

minimized.

7: <3%

6: <4%

5: <5%

4: <6%

3: <7%

2: <8%

1: <9%

0: ≥10%

M10

Yes/No) Decontamination

Decontamination procedures must

10: No negative impacts on operations.

procedures are logistically

be logistically supportable.

7: Limited negative impact on operational capability.

supportable?

5: Moderate negative impact on operational capability.

3: Major negative impact on operational capability.

0: Not logistically supportable.

M11

(Quantity) Sensitive

Number of sensitive equipment

10: >45

equipment decontaminated

items that can be thoroughly

9: 41-45

per hour.

decontaminated per hour.

8: 36-40

7: 31-35

6: 26-30

5: 21-25

4: 16-20

3: 1115

2: 6-10

1: 2-5

0: <2

M12

There is effective DOTLPF

Refers to non-materiel elements

10: DOTLPF is adequate for all tasks to be performed with this system without limitations that

in place to conduct task?

associated with the execution of a

cause significant impact upon operations.

task with the system.

7: DOTLPF is adequate for most of the tasks to be performed with this system without

limitations that cause significant impact upon operations.

5: Many critical aspects of DOTLPF for the task to be performed with this system are addressed.

3: Some critical aspects of DOTLPF for the task to be performed with this system are addressed.

0: DOTLPF is completely inadequate or does not exist for the tasks to be performed with this

system.

¹ M1 - (Yes/No) Contaminated by-products are controlled? 7: Yes, Substantial (~75%).

² M2 - (Level) Of chemical contamination after decontamination procedures. 3: Decontaminate most CWAs to a level that will allow unprotected exposure.

³ M3 - (Level) Of biological contamination after decontamination procedures. 1: Less than infective dose levels/casualty-producing toxin levels against one key threat agent.

⁴ M5 - (Yes/No) Cross-contamination is controlled? 7: Yes, Substantial (~75%).

⁵ M6 - (Time) To initiate immediate decontamination procedures. 8: <30 seconds.

⁶ M6 - (Time) To initiate operational decontamination procedures. 8: 30 minutes.

⁷ M6 - (Time) To initiate thorough decontamination procedures. 8: 45 minutes.

⁸ M7 - (Time) To conduct immediate, operational, and thorough decontamination procedures. 5: <5 minutes.

124

For Official Use Only

CBRND Functional Needs Analysis/Functional Solution Analysis

Chapter 17. Tactical Sustain Tasks

⁹ M7 - (Time) To conduct immediate, operational, and thorough decontamination procedures. 1: <30 minutes.

¹⁰ M8 - (Percent) Of systems unusable due to the effects of decontamination. 0: ≥10%.

¹¹ M9 - (Percent) Of systems that require repair or replacement due to the effects of decontamination. 0: ≥10%.

¹² M10 - Yes/No) Decontamination procedures are logistically supportable? 5: Moderate negative impact on operational capability.

¹³ M11 - (Quantity) Sensitive equipment decontaminated per hour. 1: 2-5.

¹⁴ M12 - There is effective DOTLPF in place to conduct task? 3: Some critical aspects of DOTLPF for the task to be performed with this system are addressed.

¹⁵ M1 - (Yes/No) Contaminated by-products are controlled? 3: Yes, Minimal (~25%).

¹⁶ M2 - (Level) Of chemical contamination after decontamination procedures. 0: No effective decontaminant or process.

¹⁷ M3 - (Level) Of biological contamination after decontamination procedures. 3: Less than infective dose levels/casualty-producing toxin-exposure levels against three key threat

agents.

¹⁸ M4 - (Level) Of radiological contamination after decontamination procedures. 4: <0.33 cGy/hour residual dose rate.

¹⁹ M5 - (Yes/No) Cross-contamination is controlled? 3: Yes, Minimal (~25%).

²⁰ M6 - (Time) To initiate operational decontamination procedures. 6: <1 hour.

²¹ M6 - (Time) To initiate thorough decontamination procedures. 7: 45 minutes.

²² M10 - Yes/No) Decontamination procedures are logistically supportable? 3: Major negative impact on operational capability.

²³ M1 - (Yes/No) Contaminated by-products are controlled? 5: Yes, Partial (~50%).

²⁴ M3 - (Level) Of biological contamination after decontamination procedures. 5: Less than infective dose levels/casualty-producing toxin-exposure levels against six or more key

threat agents.

²⁵ M5 - (Yes/No) Cross-contamination is controlled? 5: Yes, Partial (~50%).

²⁶ M1 - (Yes/No) Contaminated by-products are controlled? 10: Yes, Complete (100%).

²⁷ M3 - (Level) Of biological contamination after decontamination procedures. 8: 0 CFU/PFU/m²—total removal or neutralization of toxins against 15 or more key threat agents.

²⁸ M5 - (Yes/No) Cross-contamination is controlled? 10: Yes, Complete (100%).

²⁹ M7 - (Time) To conduct immediate, operational, and thorough decontamination procedures. 3: <8 minutes.

³⁰ M8 - (Percent) Of systems unusable due to the effects of decontamination. 9: <1%.

³¹ M9 - (Percent) Of systems that require repair or replacement due to the effects of decontamination. 9: <1%.

³² M11 - (Quantity) Sensitive equipment decontaminated per hour. 2: 6-10.

³³ M12 - There is effective DOTLPF in place to conduct task? 10: DOTLPF is adequate for all tasks to be performed with this system without limitations that cause significant

impact upon operations.

³⁴ M10 - Yes/No) Decontamination procedures are logistically supportable? 7: Limited negative impact on operational capability.

³⁵ M3 - (Level) Of biological contamination after decontamination procedures. 9: 0 CFU/PFU/m²—total removal or neutralization of toxins against 20 or more key threat agents.

³⁶ M4 - (Level) Of radiological contamination after decontamination procedures. 10: Total removal to natural backg1round level.

³⁷ M11 - (Quantity) Sensitive equipment decontaminated per hour. 10: >45.

³⁸ M2 - (Level) Of chemical contamination after decontamination procedures. 3: Decontaminate most CWAs to a level that will allow unprotected exposure.

³⁹ M11 - (Quantity) Sensitive equipment decontaminated per hour. 5: 21-25.

125

For Official Use Only

CBRND Functional Needs Analysis/Functional Solution Analysis

Chapter 17. Tactical Sustain Tasks

17.13.3

Functional Solution Analysis

17.13.3.1

DOTLPF Assessment Summary

This section states the deficiencies and suggests potential non-materiel solutions. If there are no

solutions or there are only partial solutions for a particular deficiency, the deficiency is then

reassessed in the IMA section.

1. Deficiency: Inadequate thorough decontamination processing rate.

Non-Materiel Solutions: None.

2. Deficiency: Decontaminants are corrosive and can damage electronics and optics.

Non-Materiel Solutions: None.

3. Deficiency: Procedural doctrine for immediate and operational decontamination is limited,

and there is no doctrine for thorough decontamination operations.

Non-Materiel Solutions: Doctrine: Revise current doctrine.

4. Deficiency: Soap and water may not remove some biological spores.

Non-Materiel Solutions: None.

5. Deficiency: Inability to decontaminate hazards on circuit boards and other porous materials.

Non-Materiel Solutions: None.

6. Deficiency: Inability to decontaminate hard-to-reach areas using current applicators.

Non-Materiel Solutions: None.

17.13.3.2

IMA Assessment Summary

Table 17.13-2 identifies which of the materiel approaches might address specific materiel gaps

identified in the DOTMLPF assessment.

126

For Official Use Only

CBRND Functional Needs Analysis/Functional Solution Analysis

Chapter 17. Tactical Sustain Tasks

17.14 Task TASUST 14: Decontaminate ship exteriors

17.14.1

Functional Area Analysis

17.14.1.1

Definition

To decontaminate the exterior of floating assets such as Navy vessels and prepositioned ships.

Excludes decontamination of sensitive equipment such as radar domes, phalanx systems, and

communication antennas. Includes minimizing effects of contaminants and decontaminants on

operations. Levels of decontamination include immediate, operational, and thorough. Objectives

of each of these levels are identified as follows:

• Immediate: Minimize casualties, save lives, and minimize spread of contamination.

• Operational: Reduce level of contamination to regenerate combat power.

• Thorough: Reduce CBRN contamination to negligible risk. Can be performed and certified

only by shipyards and floating dry docks.

17.14.1.2

Derivation

UJTL (TA 7, TA 7.1), Protection Joint Functional Concept.

17.14.1.2.1

Supported Task: OPSUST 11

17.14.1.2.2

Lateral Task: TASHA 24

17.14.1.2.3

Supporting Task: N/A

17.14.1.3

Condition

Perform this task under conditions of:

Physical

1. Extremely rough sea state. (C1.2.1.3)

2. Tropical, arctic, and arid climate. (C1.3.1)

3. All seasons. (C1.3.1.1)

4. Precipitating and stormy weather. (C1.3.1.3)

5. Hot and very cold air temperature. (C1.3.1.3.1)

6. Liquid, freezing, and frozen precipitation. (C1.3.1.3.6.1)

7. Negligible light. (C1.3.2.1)

8. Nuclear effects. (C1.3.3.1)

9. Chemical effects. (C1.3.3.2)

10. Biological effects. (C1.3.3.3)

Military

1. Stressful mission. (C2.1)

128

For Official Use Only

CBRND Functional Needs Analysis/Functional Solution Analysis

Chapter 17. Tactical Sustain Tasks

2. Location-Afloat. (C2.1.4.1)

3. Minimal to short time available. (C2.1.5)

4. Marginal forces allocated. (C2.2.3)

5. Low personnel capability. (C2.2.4)

6. Negligible personnel experience. (C2.2.4.5)

7. Severe personnel fatigue. (C2.2.4.6)

8. Ambiguous threat existence. (C2.9.3)

Civil

1. Aggressively opposed foreign public opinion. (C3.1.2)

2. Limited or negative foreign government support. (C3.1.2.3)

3. High mission priority. (C3.1.3.2)

17.14.2

Functional Needs Analysis

17.14.2.1

Capabilities and Deficiencies Assessment Summary

Table 17.14-1 presents individual and overall current, near-/mid-term, and far-term capabilities

to perform the task to the designated standard. There are a total of five current capabilities used

to accomplish this task and two projected capabilities to be added in the future. Capabilities exist

at the immediate, operational, and thorough levels of decontamination.

Current Capabilities and Deficiencies

Capabilities exist at the immediate, operational, and thorough levels involving the use of

countermeasure washdown systems, HTH, water, general detergents, steam, and appropriate

applicators. There are some capabilities that work better than others, but effectiveness is always

increased when more than one capability is utilized. The best overall capability is the use of

HTH/STB for chemical and biological agents. For radiological agents, however, general

detergents mixed with water are recommended. The downside of HTH/STB is that they are

corrosive to surfaces and equipment and can be hazardous to personnel.

Projected Near/Mid-Term Capabilities and Deficiencies

The projected near/mid-term capabilities and deficiencies evaluated were associated with

JSTDS-SS Increment I.

Projected Far-Term Capabilities and Deficiencies

The projected far-term capabilities and deficiencies evaluated were associated with JSTDS-SS

Increment II and JPDS Increments I and II.

129

For Official Use Only

For Official Use Only

CBRND Functional Needs Analysis/Functional Solution Analysis

Chapter 17. Tactical Sustain Tasks

Table 17.14-1. TASUST 14: Capabilities and Deficiencies Assessment

M10

M11

Capabilities

Current

Seawater/CMWD/

3¹

3²

3³

N/A

4⁴

3⁵

9⁶

9⁷

8⁸

9⁹

7¹⁰

N/A

10¹¹

Firemain Systems

HTH

5¹²

5¹³

N/A

8¹⁴

1¹⁵

5¹⁶

3¹⁷

N/A

7¹⁸

General Detergent

0¹⁹

N/A

Steam

0²⁰

N/A

0²¹

N/A

Gross Physical

Removal/Shipyard

N/A

5²²

10²³

N/A

5²⁵

3²⁶

0²⁷

N/A

5²⁸

and Floating

Drydock

Near/Mid-Term

JSTDS-SS

7²⁹

N/A

7³⁰

5³¹

5³²

N/A

Increment I

Far-Term

JSTDS-SS

10³³

N/A

10³⁴

N/A

Increment II

JPDS Increment I/II

5³⁵

Current Overall

4³⁶

3³⁸

2³⁹

Capabilities

Near/Mid-Term

Overall

Capabilities

Far-Term Overall

Capabilities

FAA Measure

Elaboration

Scale

(Yes/No) Contaminated by-products are

Contaminated by-products are controlled.

10: Yes, Complete (100%).

controlled?

Where by-products are less than 100%

7: Yes, Substantial (~75%).

controlled, measures must be in place to

5: Yes, Partial (~50%).

prevent by-products from becoming an

3: Yes, Minimal (~25%).

unacceptable hazard.

0: No, Contaminated by-products cannot be controlled and

present an unacceptable hazard.

130

For Official Use Only

CBRND Functional Needs Analysis/Functional Solution Analysis

Chapter 17. Tactical Sustain Tasks

(Level) Of chemical contamination

The level of chemical contamination is

10: Decontaminate all CWAs, NTAs, TIMs to general

after decontamination procedures.

acceptable after decontamination

population exposure limits.

operations from a starting liquid

7: Decontaminate all CWAs, all NTAs, and some TIMs to a

challenge of 10 g/m². Agents defined as

level that will allow unprotected exposure.

current-generation CWAs, NTAs, TIMs,

5: Decontaminate all CWAs and some NTAs to a level that will

and TICs.

allow unprotected exposure.

3: Decontaminate most CWAs to a level that will allow

unprotected exposure.

0: No effective decontaminant or process.

(Level) Of biological contamination

The level of biological contamination is

10: 0 CFU/PFU/m²—total removal or neutralization of toxins

after decontamination procedures.

acceptable after decontamination

against all 25 threat agents.

procedures. Vegetative and nonvegetative

9: 0 CFU/PFU/m²—total removal or neutralization of toxins

bacteria are measured in CFU/m², and

against 20 or more key threat agents.

viruses are measured in PFU/m².

8: 0 CFU/PFU/m²—total removal or neutralization of toxins

against 15 or more key threat agents.

7: 0 CFU/PFU/m²—total removal or neutralization of toxins

against 10 or more key threat agents.

6: 0 CFU/PFU/m²—total removal or neutralization of toxins

against eight or more key threat agents.

5: Less than infective dose levels/casualty-producing toxin

exposure levels against six or more key threat agents.

4: Less than infective dose levels/casualty-producing toxin

exposure levels against four key threat agents.

3: Less than infective dose levels/casualty-producing toxin

exposure levels against three key threat agents.

2: Less than infective dose levels/casualty-producing toxin

exposure levels against two or more key threat agents.

1: Less than infective dose levels/casualty-producing toxin

levels against one key threat agent.

0: More than infective dose levels/casualty-producing toxin

exposure levels.

131

For Official Use Only

CBRND Functional Needs Analysis/Functional Solution Analysis

Chapter 17. Tactical Sustain Tasks

(Level) Of radiological contamination

The level of radiological contamination is

10: Total removal to natural backg1round level.

after decontamination procedures.

acceptable after decontamination

8: ≤0.11 cGy/hour residual dose rate.

operations from a starting challenge of

6: ≤0.22 cGy/hour residual dose rate.

4 g/m² of insoluble radioactive

4: <0.33 cGy/hour residual dose rate.

contaminants, 37-200 μm in size and

2: 0.33 cGy/hour residual dose rate.

185 GBq/m²gamma activity.

0: Removal capabilities limited or ineffective, allowing

0.33 cGy/hour equates to an exposure that

excessive residual dose rates >0.33 cGy/hour.

can cause mild incapacitation in 2.5% or

less of unprotected, not previously

exposed personnel.

(Yes/No) Cross-contamination is

Cross-contamination is controlled. Where

10: Yes, Complete (100%).

controlled?

cross-contamination is less than 100%

7: Yes, Substantial (~75%).

controlled, measures must be in place to

5: Yes, Partial (~50%).

prevent cross-contamination from

3: Yes, Minimal (~25%).

becoming an unacceptable hazard.

0: No, Cross-contamination cannot be controlled and presents

an unacceptable hazard.

(Time) To initiate immediate and

Initiate immediate decontamination

Immediate

Operational

operational decontamination

procedures within adequate amount of

10: Immediately

procedures.

time.

9: <1 minute

9: 15 minutes

8: <2 minutes

8: 30 minutes

Initiate operational decontamination

7: <3 minutes

7: 45 minutes

procedures within adequate amount of

6: <4 minutes

6: <1 hour

time.

5: <5 minutes

5: <2 hours

4: <7 minutes

4: <3 hours

3: <9 minutes

3: <4 hours

2: <12 minutes

2: <5 hours

1: <15 minutes

1: <6 hours

0: >15 minutes

0: >6 hours

(Time) To conduct immediate and

Time required for one warfighter to carry

10: Immediately

operational decontamination

out immediate or operational

9: <1 minute

procedures.

decontamination procedures on 300 m² of

8: <2 minutes

surface area.

7: <3 minutes

6: <4 minutes

5: <5 minutes

4: <7 minutes

3: <9 minutes

2: <12 minutes

1: <15 minutes

0: >15 minutes

132

For Official Use Only

CBRND Functional Needs Analysis/Functional Solution Analysis

Chapter 17. Tactical Sustain Tasks

(Percent) Of systems that require repair

The quantity of repairs or parts

10: 0%

or replacement due to the effects of

replacements required due to

9: <1%

decontamination.

decontamination process must be

8: <2%

minimized.

7: <3%

6: <4%

5: <5%

4: <6%

3: <7%

2: <8%

1: <9%

0: ≥10%

(Yes/No) Decontamination procedures

Decontamination procedures must be

10: No negative impacts on operations.

are logistically supportable?

logistically supportable.

7: Limited negative impact on operational capability.

5: Moderate negative impact on operational capability.

3: Major negative impact on operational capability.

0: Not logistically supportable.

M10

(Time) To conduct thorough

Time required for one warfighter to carry

10: Immediately

decontamination.

out thorough decontamination procedures

9: <1 minute

on 300 m² of surface area.

8: <2 minutes

7: <3 minutes

6: <4 minutes

5: <5 minutes

4: <10 minutes

3: <15 minutes

2: <20 minutes

1: <30 minutes

0: >30 minutes

M11

(Yes/No) There is effective DOTLPF in

Refers to non-materiel elements

10: DOTLPF is adequate for all tasks to be performed with this

place to conduct task?

associated with the execution of a task

system without limitations that cause significant impact upon

with the system.

operations.

7: DOTLPF is adequate for most of the tasks to be performed

with this system without limitations that cause significant

impact upon operations.

5: Many critical aspects of DOTLPF for the task to be

performed with this system are addressed.

3: Some critical aspects of DOTLPF for the task to be

performed with this system are addressed.

0: DOTLPF is completely inadequate or does not exist for the

tasks to be performed with this system.

133

For Official Use Only

CBRND Functional Needs Analysis/Functional Solution Analysis

Chapter 17. Tactical Sustain Tasks

¹ M1 - (Yes/No) Contaminated by-products are controlled? 3: Yes, Minimal (~25%).

² M2 - (Level) Of chemical contamination after decontamination procedures. 3: Decontaminate most CWAs to a level that will allow unprotected exposure.

³ M3 - (Level) Of biological contamination after decontamination procedures. 3: Less than infective dose levels/casualty-producing toxin-exposure levels against three key threat

agents.

⁴ M4 - (Level) Of radiological contamination after decontamination procedures. 4: <0.33 cGy/hour residual dose rate.

⁵ M5 - (Yes/No) Cross-contamination is controlled? 5: Yes, Partial (~50%).

⁶ M6 - (Time) To initiate immediate decontamination procedures. 9: <1 minute.

⁷ M6 - (Time) To initiate operational decontamination procedures. 9: 15 minutes.

⁸ M7 - (Time) To conduct immediate and operational decontamination procedures. 8: <2 minutes.

⁹ M8 - (Percent) Of systems that require repair or replacement due to the effects of decontamination. 9: <1%.

¹⁰ M9 - (Yes/No) Decontamination procedures are logistically supportable? 7: Limited negative impact on operational capability.

¹¹ M11 - (Yes/No) There is effective DOTLPF in place to conduct task? 10: DOTLPF is adequate for all tasks to be performed with this system without limitations that cause

significant impact upon operations.

¹² M1 - (Yes/No) Contaminated by-products are controlled? 5: Yes, Partial (~50%).

¹³ M3 - (Level) Of biological contamination after decontamination procedures. 5: Less than infective dose levels/casualty-producing toxin-exposure levels against six or more key

threat agents.

¹⁴ M6 - (Time) To initiate operational decontamination procedures. 8: 30 minutes.

¹⁵ M7 - (Time) To conduct immediate and operational decontamination procedures. 1: <15 minutes

¹⁶ M9 - (Yes/No) Decontamination procedures are logistically supportable? 5: Moderate negative impact on operational capability.

¹⁷ M10 - (Time) To conduct thorough decontamination. 3: <15minutes.

¹⁸ M11 - (Yes/No) There is effective DOTLPF in place to conduct task? 7: DOTLPF is adequate for most of the tasks to be performed with this system without limitations that

cause significant impact upon operations.

¹⁹ M2 - (Level) Of chemical contamination after decontamination procedures. 0: No effective decontaminant or process.

²⁰ M1 - (Yes/No) Contaminated by-products are controlled? 0: No, Contaminated by-products cannot be controlled and present an unacceptable hazard.

²¹ M5 - (Yes/No) Cross-contamination is controlled? 0: No, cross-contamination cannot be controlled and presents an unacceptable hazard.

²² M2 - (Level) Of chemical contamination after decontamination procedures. 5: Decontaminate all CWAs, some NTAs to a level that will allow unprotected exposure.

²³ M3 - (Level) Of biological contamination after decontamination procedures. 10: 0 CFU/PFU/m²—total removal or neutralization of toxins against all 25 threat agents.

²⁴ M4 - (Level) Of radiological contamination after decontamination procedures. 10: Total removal to natural backg1round level.

²⁵ M5 - (Yes/No) Cross-contamination is controlled? 5: Yes, Partial (~50%).

²⁶ M9 - (Yes/No) Decontamination procedures are logistically supportable? 3: Major negative impact on operational capability.

²⁷ M10 - (Time) To conduct thorough decontamination. 0: >30 minutes.

²⁸ M11 - (Yes/No) There is effective DOTLPF in place to conduct task? 5: Many critical aspects of DOTLPF for the task to be performed with this system are addressed.

²⁹ M1 - (Yes/No) Contaminated by-products are controlled? 7: Yes, Substantial (~75%).

³⁰ M5 - (Yes/No) Cross-contamination is controlled? 7: Yes, Substantial (~75%).

³¹ M7 - (Time) To conduct immediate and operational decontamination procedures. 5: <5 minutes.

³² M10 - (Time) To conduct thorough decontamination. 5: <5 minutes.

³³ M1 - (Yes/No) Contaminated by-products are controlled? 10: Yes, Complete (100%).

³⁴ M5 - (Yes/No) Cross-contamination is controlled? 10: Yes, Complete (100%).

³⁵ M7 - (Time) To conduct immediate and operational decontamination procedures. 5: <5 minutes.

³⁶ M3 - (Level) Of biological contamination after decontamination procedures. 4: Less than infective dose levels/casualty-producing toxin-exposure levels against four key threat

agents.

³⁷ M4 - (Level) Of radiological contamination after decontamination procedures. 6: ≤0.22 cGy/hour residual dose rate.

³⁸ M7 - (Time) To conduct immediate and operational decontamination procedures. 3: <9 minutes.

134

For Official Use Only

CBRND Functional Needs Analysis/Functional Solution Analysis

Chapter 17. Tactical Sustain Tasks

17.14.3

Functional Solution Analysis

17.14.3.1

DOTLPF Assessment Summary

This section states the deficiencies and suggests potential non-materiel solutions. If there are no

solutions or there are only partial solutions for a particular deficiency, the deficiency is then

reassessed in the IMA section.

Deficiency: Washdown is corrosive.

Non-Materiel Solutions: Doctrine: Include freshwater rinse after the securing of the

CMWD. Include CMWD and chemical and biological (CB) detectors precautionary

measures in NWP 3-20.31.

Deficiency: Countermeasure washdown does not neutralize CBRN contamination.

Non-Materiel Solutions: None.

Deficiency: CMWD delivery system has insufficient nozzles to cover all surfaces.

Non-Materiel Solutions: Doctrine: Increase area coverage requirements. Conduct CMWD

area coverage analysis and initiate ship alteration or repair requirements as necessary.

Deficiency: Not all deck drains discharge over the side of the ship.

Non-Materiel Solutions: Conduct ship exterior drainage analysis and initiate ship alteration

or repair requirements as necessary.

Deficiency: Primary ship decontaminant (HTH) is hazardous and corrosive.

Non-Materiel Solutions: Doctrine (partial): Modify doctrine to include water rinse after

HTH application.

Deficiency: Limited capability to decontaminate remote and hard-to-reach surfaces using

current applicators.

Non-Materiel Solutions: None.

Deficiency: Inability to decontaminate ventilation system exterior inlets.

Non-Materiel Solutions: Doctrine (partial): Develop decontamination methodology for

ventilation interiors.

Deficiency: Limited capability to decontaminate painted or porous surfaces.

Non-Materiel Solutions: None.

Deficiency: No doctrine for physical removal of agent from painted or porous surfaces.

Non-Materiel Solutions: Doctrine: Need NSTM Chapter 470 Revision.

17.14.3.2

IMA Assessment Summary

Table 17.14-2 identifies which of the materiel approaches might address specific materiel gaps

identified in the DOTMLPF assessment.

136

For Official Use Only

CBRND Functional Needs Analysis/Functional Solution Analysis

Chapter 17. Tactical Sustain Tasks

17.15 Task TASUST 15: Decontaminate ship interiors

17.15.1

Functional Area Analysis

17.15.1.1

Definition

To decontaminate the interior of floating assets such as Navy vessels and prepositioned ships.

Includes minimizing effects of contaminants and decontaminants on operations. Levels of

decontamination include immediate, operational, and thorough. Objectives of each of these

levels are identified as follows:

• Immediate: Minimize casualties, save lives, and minimize spread of contamination.

• Operational: Reduce level of contamination to regenerate combat power.

• Thorough: Reduce CBRN contamination to negligible risk.

17.15.1.2

Derivation

UJTL (TA 7, TA 7.1), Protection Joint Functional Concept.

17.15.1.2.1

Supported Task: OPSUST 11

17.15.1.2.2

Lateral Task: TASHA 24

17.15.1.2.3

Supporting Task: N/A

17.15.1.3

Condition

Perform this task under conditions of:

Physical

1. Extremely rough sea state. (C1.2.1.3)

2. Hot and very cold air temperature. (C1.3.1.3.1)

3. Negligible light. (C1.3.2.1)

4. Nuclear effects. (C1.3.3.1)

5. Chemical effects. (C1.3.3.2)

6. Biological effects. (C1.3.3.3)

Military

1. Stressful mission. (C2.1)

2. Location—afloat. (C2.1.4.1)

3. Minimal to short time available. (C2.1.5)

4. Marginal forces allocated. (C2.2.3)

5. Low personnel capability. (C2.2.4)

6. Negligible personnel experience. (C2.2.4.5)

7. Severe personnel fatigue. (C2.2.4.6)

138

For Official Use Only

CBRND Functional Needs Analysis/Functional Solution Analysis

Chapter 17. Tactical Sustain Tasks

8. Ambiguous threat existence. (C2.9.3)

Civil

1. Limited or negative foreign government support. (C3.1.2.3)

2. Aggressively opposed foreign public opinion. (C3.1.2.4)

3. High mission priority. (C3.1.3.2)

17.15.2

Functional Needs Analysis

17.15.2.1

Capabilities and Deficiencies Assessment Summary

Table 17.15-1 presents individual and overall current, near-/mid-term, and far-term capabilities

to perform the task to the designated standard. There are a total of five current capabilities used

to accomplish this task and two projected capabilities to be added in the future. Capabilities exist

at the immediate, operational, and thorough levels of decontamination associated with the

decontamination of ship interiors.

Current Capabilities and Deficiencies

The current capabilities and deficiencies associated with the decontamination of ship interiors.

Capabilities for ship interiors encompass HTH, STB, and soap and water applied with scrub

brushes and mops. Deficiencies include the potential damage to systems with the use of

corrosive decontaminants, as well as the limited ability to decontaminate porous, painted, and

hard-to-reach surfaces. Other major deficiencies include the inability to decontaminate interior

ventilation systems. Also with current decontaminants there is a limited capability to remove

suspended agents from the atmosphere.

Projected Near/Mid-Term Capabilities and Deficiencies

The projected near/mid-term capabilities and deficiencies evaluated were associated with JPID

Increment I.

Projected Far-Term Capabilities and Deficiencies

The projected near/mid-term capabilities and deficiencies evaluated were associated with JPDS

Increments I and II and JPID Increment II.

139

For Official Use Only

For Official Use Only

CBRND Functional Needs Analysis/Functional Solution Analysis

Chapter 17. Tactical Sustain Tasks

Table 17.15-1. TASUST 15: Capabilities and Deficiencies Assessment

M10

M11

M12

Capabilities

Current

Topical

Disinfectant

7¹

6²

N/A

7³

5⁴

5⁵

1⁶

9⁷

7⁸

5⁹

1¹⁰

3¹¹

Solutions

HTH

5¹²

3¹³

5¹⁴

N/A

3¹⁵

5¹⁶

General

3¹⁸

0¹⁹

3²⁰

4²¹

Detergent

Steam

0²²

N/A

0²³

N/A

Gross

Physical

Removal/

10²⁵

8²⁶

0²⁷

N/A

Shipyard/

Floating

Drydock

Near/Mid-Term

JPID

7³⁰

5³²

7³³

Increment I

Far-Term

JPID

8³⁵

8³⁶

Increment II

JPDS

Increment

N/A

5³⁸

I/II

Current

Overall

3³⁹

4⁴⁰

Capabilities

Near/Mid-

Term

Overall

Capabilities

Far-Term

Overall

Capabilities

140

For Official Use Only

CBRND Functional Needs Analysis/Functional Solution Analysis

Chapter 17. Tactical Sustain Tasks

FAA Measure

Elaboration

Scale

(Yes/No) Contaminated by-products

Contaminated by-products are

10: Yes, Complete (100%).

are controlled?

controlled. Where by-products are less

7: Yes, Substantial (~75%).

than 100% controlled, measures must

5: Yes, Partial (~50%).

be in place to prevent by-products from

3: Yes, Minimal (~25%).

becoming an unacceptable hazard.

0: No, Contaminated by-products cannot be controlled and present

an unacceptable hazard.

(Level) Of chemical contamination

The level of chemical contamination is

10: Decontaminate all CWAs, NTAs, TIMs to general population

after decontamination procedures.

acceptable after decontamination

exposure limits.

operations from a starting liquid

7: Decontaminate all CWAs, all NTAs, and some TIMs to a level

challenge of 1 g/m². Agents defined as

that will allow unprotected exposure.

current-generation CWAs, NTAs,

5: Decontaminate all CWAs and some NTAs to a level that will

TIMs, and TICs.

allow unprotected exposure.

3: Decontaminate most CWAs to a level that will allow

unprotected exposure.

0: No effective decontaminant or process.

(Level) Of biological contamination

The level of biological contamination is

10: 0 CFU/PFU/m²—total removal or neutralization of toxins

after decontamination procedures.

acceptable after decontamination

against all 25 threat agents.

procedures. Vegetative and

9: 0 CFU/PFU/m²—total removal or neutralization of toxins

nonvegetative bacteria are measured in

against 20 or more key threat agents.

CFU/m² and viruses are measured in

8: 0 CFU/PFU/m²—total removal or neutralization of toxins

PFU/m².

against 15 or more key threat agents.

7: 0 CFU/PFU/m²—total removal or neutralization of toxins

against 10 or more key threat agents.

6: 0 CFU/PFU/m²—total removal or neutralization of toxins

against eight or more key threat agents.

5: Less than infective dose levels/casualty-producing toxin

exposure levels against six or more key threat agents.

4: Less than infective dose levels/casualty-producing toxin

exposure levels against four key threat agents.

3: Less than infective dose levels/casualty-producing toxin

exposure levels against three key threat agents.

2: Less than infective dose levels/casualty-producing toxin

exposure levels against two or more key threat agents.

1: Less than infective dose levels/casualty-producing toxin levels

against one key threat agent.

0: More than infective dose levels/casualty-producing toxin

exposure levels.

141

For Official Use Only

CBRND Functional Needs Analysis/Functional Solution Analysis

Chapter 17. Tactical Sustain Tasks

(Level) Of radiological contamination

The level of radiological contamination

10: Total removal to natural backg1round level.

after decontamination procedures.

is acceptable after decontamination

8: ≤0.11 cGy/hour residual dose rate.

operations from a starting challenge of

6: ≤0.22 cGy/hour residual dose rate.

0.4 g/m² of insoluble radioactive

4: <0.33 cGy/hour residual dose rate.

contaminants, 37-200 μm in size and

2: 0.33 cGy/hour residual dose rate.

185 GBq/m²gamma activity.

0: Removal capabilities limited or ineffective, allowing excessive

0.33 cGy/hour equates to an exposure

residual dose rates >0.33 cGy/hour.

that can cause mild incapacitation in

2.5% or less of unprotected, not

previously exposed personnel.

(Yes/No) Cross-contamination is

Cross-contamination is controlled.

10: Yes, Complete (100%).

controlled?

Where cross-contamination is less than

7: Yes, Substantial (~75%).

100% controlled, measures must be in

5: Yes, Partial (~50%).

place to prevent cross-contamination

3: Yes, Minimal (~25%).

from becoming an unacceptable hazard.

0: No, Cross-contamination cannot be controlled and presents an

unacceptable hazard.

(Time) To initiate immediate and

Initiate immediate decontamination

Immediate

Operational

operational decontamination

procedures in time to meet mission

10: Immediately

procedures.

requirements.

9: <1 minute

9: 15 minutes

8: <2 minutes

8: 30 minutes

Initiate operational decontamination

7: <3 minutes

7: 45 minutes

procedures in time to meet mission

6: <4 minutes

6: <1 hour

requirements.

5: <5 minutes

5: <2 hours

4: <7 minutes

4: <3 hours

3: <9 minutes

3: <4 hours

2: <12 minutes

2: <5 hours

1: <15 minutes

1: <6 hours

0: >15 minutes

0: >6 hours

(Time) To conduct immediate and

Time required for one warfighter to

10: Immediately

operational decontamination

carry out immediate and operational

9: <1 minute

procedures.

decontamination procedures on 300 m²

8: <2 minutes

of surface area.

7: <3 minutes

6: <4 minutes

5: <5 minutes

4: <7 minutes

3: <9 minutes

2: <12 minutes

1: <15 minutes

0: >15 minutes

142

For Official Use Only

CBRND Functional Needs Analysis/Functional Solution Analysis

Chapter 17. Tactical Sustain Tasks

(Percent) Of interior areas/systems

The quantity of systems that may be

10: 0%

unusable due to the effects of

rendered unserviceable by

9: <1%

decontamination.

decontamination process must be

8: <2%

minimized.

7: <3%

6: <4%

5: <5%

4: <6%

3: <7%

2: <8%

1: <9%

0: ≥10%

(Percent) Of systems that require

The quantity of repairs or parts

10: 0%

repair or replacement due to the

replacements required due to

9: <1%

effects of decontamination.

decontamination process must be

8: <2%

minimized.

7: <3%

6: <4%

5: <5%

4: <6%

3: <7%

2: <8%

1: <9%

0: ≥10%

M10

(Yes/No) Decontamination

Decontamination procedures must be

10: No negative impacts on operations.

procedures are logistically

logistically supportable.

7: Limited negative impact on operational capability.

supportable?

5: Moderate negative impact on operational capability.

3: Major negative impact on operational capability.

0: Not logistically supportable.

M11

(Time) To conduct thorough

Time required for one warfighter to

10: Immediately

decontamination.

carry out thorough decontamination

9: <1 minute

procedures on 300 m² of surface area.

8: <2 minutes

7: <3 minutes

6: <4 minutes

5: <5 minutes

4: <10 minutes

3: <15 minutes

2: <20 minutes

1: <30 minutes

0: >30 minutes

143

For Official Use Only

CBRND Functional Needs Analysis/Functional Solution Analysis

Chapter 17. Tactical Sustain Tasks

M12

(Yes/No) There is effective DOTLPF

Refers to non-materiel elements

10: DOTLPF is adequate for all tasks to be performed with this

in place to conduct task?

associated with the execution of a task

system without limitations that cause significant impact upon

with the system.

operations.

7: DOTLPF is adequate for most of the tasks to be performed with

this system without limitations that cause significant impact upon

operations.

5: Many critical aspects of DOTLPF for the task to be performed

with this system are addressed.

3: Some critical aspects of DOTLPF for the task to be performed

with this system are addressed.

0: DOTLPF is completely inadequate or does not exist for the

tasks to be performed with this system.

¹ M1 - (Yes/No) Contaminated by-products are controlled? 7: Yes, Substantial (~75%).

² M3 - (Level) Of biological contamination after decontamination procedures. 6: 0 CFU/PFU/m²—total removal or neutralization of toxins against eight or more key threat agents.

³ M5 - (Yes/No) Cross-contamination is controlled? 7: Yes, Substantial (~75%).

⁴ M6 - (Time) To initiate immediate decontamination procedures. 5: <5 minutes.

⁵ M6 - (Time) To initiate operational decontamination procedures. 5: <2 hours.

⁶ M7 - (Time) To conduct immediate and operational decontamination procedures. 1: <15 minutes.

⁷ M8 - (Percent) Of interior areas/systems unusable due to the effects of decontamination. 9: <1%.

⁸ M9 - (Percent) Of systems that require repair or replacement due to the effects of decontamination. 7: <3%.

⁹ M10 - (Yes/No) Decontamination procedures are logistically supportable? 5: Moderate negative impact on operational capability.

¹⁰ M11 - (Time) To conduct thorough decontamination. 1: <30 minutes.

¹¹ M12 - (Yes/No) There is effective DOTLPF in place to conduct task? 3: Some critical aspects of DOTLPF for the task to be performed with this system are addressed.

¹² M1 - (Yes/No) Contaminated by-products are controlled? 5: Yes, Partial (~50%).

¹³ M2 - (Level) Of chemical contamination after decontamination procedures. 3: Decontaminate most CWAs to a level that will allow unprotected exposure.

¹⁴ M3 - (Level) Of biological contamination after decontamination procedures. 5: Less than infective dose levels/casualty-producing toxin-exposure levels against six or more key

threat agents.

¹⁵ M5 - (Yes/No) Cross-contamination is controlled? 3: Yes, Minimal (~25%).

¹⁶ M5 - (Yes/No) Cross-contamination is controlled? 5: Yes, Partial (~50%).

¹⁷ M12 - (Yes/No) There is effective DOTLPF in place to conduct task? 7: DOTLPF is adequate for most of the tasks to be performed with this system without limitations that

cause significant impact upon operations.

¹⁸ M1 - (Yes/No) Contaminated by-products are controlled? 3: Yes, Minimal (~25%).

¹⁹ M2 - (Level) Of chemical contamination after decontamination procedures. 0: No effective decontaminant or process.

²⁰ M3 - (Level) Of biological contamination after decontamination procedures. 3: Less than infective dose levels/casualty-producing toxin-exposure levels against three key threat

agents.

²¹ M4 - (Level) Of radiological contamination after decontamination procedures. 4: <0.33 cGy/hour residual dose rate.

²² M1 - (Yes/No) Contaminated by-products are controlled? 0: No, Contaminated by-products cannot be controlled and present an unacceptable hazard.

²³ M5 - (Yes/No) Cross-contamination is controlled? 0: No, cross-contamination cannot be controlled and presents an unacceptable hazard.

²⁴ M3 - (Level) Of biological contamination after decontamination procedures. 10: 0 CFU/PFU/m²—total removal or neutralization of toxins against all 25 threat agents.

²⁵ M4 - (Level) Of radiological contamination after decontamination procedures. 10: Total removal to natural backg1round level.

²⁶ M9 - (Percent) Of systems that require repair or replacement due to the effects of decontamination. 8: <2%.

²⁷ M11 - (Time) To conduct thorough decontamination. 0: >30 minutes.

144

For Official Use Only

CBRND Functional Needs Analysis/Functional Solution Analysis

Chapter 17. Tactical Sustain Tasks

²⁸ M12 - (Yes/No) There is effective DOTLPF in place to conduct task? 5: Many critical aspects of DOTLPF for the task to be performed with this system are addressed.

²⁹ M1 - (Yes/No) Contaminated by-products are controlled? 10: Yes, Complete (100%).

³⁰ M3 - (Level) Of biological contamination after decontamination procedures. 7: 0 CFU/PFU/m²—total removal or neutralization of toxins against 10 or more key threat agents.

³¹ M5 - (Yes/No) Cross-contamination is controlled? 10: Yes, Complete (100%).

³² M7 - (Time) To conduct immediate and operational decontamination procedures. 5: <5 minutes.

³³ M10 - (Yes/No) Decontamination procedures are logistically supportable? 7: Limited negative impact on operational capability.

³⁴ M2 - (Level) Of chemical contamination after decontamination procedures. 5: Decontaminate all CWAs, some NTAs to a level that will allow unprotected exposure.

³⁵ M3 - (Level) Of biological contamination after decontamination procedures. 8: 0 CFU/PFU/m²—total removal or neutralization of toxins against 15 or more key threat agents.

³⁶ M4 - (Level) Of radiological contamination after decontamination procedures. 8: ≤0.11 cGy/hour residual dose rate.

³⁷ M12 - (Yes/No) There is effective DOTLPF in place to conduct task? 10: DOTLPF is adequate for all tasks to be performed with this system without limitations that cause

significant impact upon operations.

³⁸ M11 - (Time) To conduct thorough decontamination. 5: <5 minutes.

³⁹ M2 - (Level) Of chemical contamination after decontamination procedures. 3: Decontaminate most CWAs to a level that will allow unprotected exposure.

⁴⁰ M3 - (Level) Of biological contamination after decontamination procedures. 4: Less than infective dose levels/casualty-producing toxin-exposure levels against four key threat

agents.

145

For Official Use Only

CHEMICAL, BIOLOGICAL, RADIOLOGICAL, AND NUCLEAR DEFENSE (CBRND) FUNCTIONAL NEEDS ANALYSIS. FINAL REPORT (2005) - page 28